u/Fluffy-Lead6201

• OTCQB: SWISF: recently referenced around US$0.05, with Sekur still trading as a micro-cap cybersecurity name.
• Latest catalyst: Sekur is heading to SOF Week 2026 in Tampa to demonstrate SekurVoice to special operations, defense, and acquisition audiences.
• Investor angle: if SWISF can turn defense visibility into partnerships, channel agreements, or paid operator accounts, SekurVoice could become the company’s clearest revenue catalyst.

Sekur Private Data (OTCQB: SWISF) is trying to position itself around a simple but high-stakes problem: when communications fail, missions can fail. The recent Internet Stock Review article framed SekurVoice around exactly that idea, using the Russia-Ukraine war as a real-world example of why unsecured communication channels can become a battlefield liability.

For investors, the SWISF story is becoming more focused. Sekur is not trying to be another generic cybersecurity platform. It is trying to build Swiss-hosted, defense-grade secure communications tools for users that cannot afford interception, surveillance, identity exposure, or network compromise.

Market Catalyst: Secure Communications Are Becoming Mission-Critical

Secure communications are now part of the defense and cybersecurity stack. Military users, government agencies, intelligence-linked personnel, defense contractors, executives, journalists, and high-risk organizations all face threats from interception, signals exploitation, phishing, surveillance, and data leaks.

The defense market is also becoming more open to communications tools that can operate outside ordinary telecom infrastructure. The article highlights that SOF Week is expected to bring together a large special operations ecosystem, including operators, commanders, acquisition professionals, government leaders, and defense industry partners.

Two numbers make this event important for SWISF investors:

• SOF Week 2026 runs from May 18 to May 21 in Tampa, giving Sekur a near-term opportunity to demonstrate SekurVoice directly to defense and special operations audiences.
• The event is described as drawing more than 23,000 attendees from 60 nations, which gives Sekur access to the exact buyer ecosystem it is trying to reach.

This does not guarantee contracts. But for a micro-cap company like SWISF, direct exposure to procurement decision-makers and special operations buyers can matter if meetings convert into pilots, partnerships, or recurring accounts.

The Core Product: SekurVoice

SekurVoice is the center of the story. The article says SWISF will demonstrate SekurVoice at SOF Week as a solution designed for sensitive, covert, or classified-adjacent communications. Sekur’s CEO, Alain Ghiai, said the product was designed to bypass traditional telecommunications infrastructure and reduce exposure to interception, signals exploitation, and network surveillance.

• Investor data point: Sekur’s prior update said SekurVoice plans start at US$3,500/year, and management projected at least 1,000 operator accounts over 12–18 months, implying about US$3.5M of potential annual revenue if achieved.

That pricing structure matters. For OTCQB: SWISF, even a few million dollars of recurring operator revenue could be meaningful because the company’s valuation remains small relative to scaled cybersecurity peers.

Why SOF Week Matters

SOF Week is not a typical trade show for Sekur. It is a concentrated defense audience. The Internet Stock Review article says Sekur’s national security team will be present, including advisors connected to U.S. Special Operations experience, and that the company expects to meet procurement decision-makers, SOCOM leadership, acquisition officers, U.S. Special Operations Forces, and partner-nation defense components.

That is important because defense communications is a relationship-heavy and trust-heavy market. SWISF still has to prove product-market fit, but the right audience can shorten the distance between product demonstration and real buyer feedback.

The article also says Sekur has been contacted by dozens of senior executives and defense-sector technology advisors interested in learning more about its secure communication tools. For investors, the next question is whether those conversations lead to announced channel agreements or contracts.

Product Stack: Beyond One Voice Tool

Sekur’s broader offering includes SekurMail, SekurMessenger, SekurVPN, and SekurRelay. The reason this matters is that defense and government customers often need more than one tool. They may need secure command email, hardened messaging, encrypted file transfer, VPN protection, identity obfuscation, and deployment flexibility.

For SWISF, SekurRelay could be especially useful because it can support phased adoption. Large organizations rarely migrate every communication layer at once. A product that allows command-level, executive, or senior-staff deployment first could reduce friction and make early adoption more realistic.

Revenue Scenario From Operator Accounts

This is not company guidance, but a simple investor scenario using Sekur’s stated US$3,500/year starting price for SekurVoice and the previously discussed 1,000 operator account target.

Scenario	Operator Accounts	Annual Price/User	Potential Annual Revenue
Early Adoption	250	US$3,500	US$875,000
Stated Target Case	1,000	US$3,500	US$3.5M
Expanded Defense Adoption	2,500	US$3,500	US$8.75M

The math is why SWISF is worth watching. If the company can turn defense demonstrations into recurring accounts, revenue could scale from a small base. But the risk is equally clear: until paid adoption is proven, the opportunity remains speculative.

Stock Snapshot

Metric	Snapshot
Company	Sekur Private Data Ltd.
Ticker	OTCQB: SWISF
Recent referenced price	Around US$0.05 in Internet Stock Review article
Sector	Cybersecurity / secure communications
Key product	SekurVoice
Near-term event	SOF Week, May 18–21, 2026
Reported audience	23,000+ attendees from 60 nations
Main investor angle	Defense-grade secure communications for high-risk users

What Investors Should Watch

The next signals for SWISF are straightforward: SOF Week meetings, product demonstrations, announced partnerships, channel agreements, pilot programs, and paid SekurVoice accounts. Technical chart commentary can help traders track sentiment, but fundamentals will matter more if Sekur wants a durable re-rating.

Investors should also monitor dilution, cash burn, and whether the company can execute after the conference. Defense procurement cycles can be slow, and early interest does not always become revenue.

Bottom Line

Sekur’s SOF Week push gives SWISF a more concrete defense communications catalyst. SekurVoice now has a clearer audience, pricing framework, and mission-critical use case.

The opportunity is that even modest recurring operator revenue could matter at Sekur’s micro-cap scale. The risk is execution: SWISF still needs to convert interest into paid accounts, partnerships, and repeatable revenue.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• OTCQB: SWISF: recently referenced around US$0.05, with Sekur still trading as a micro-cap cybersecurity name.
• Latest catalyst: Sekur is heading to SOF Week 2026 in Tampa to demonstrate SekurVoice to special operations, defense, and acquisition audiences.
• Investor angle: if SWISF can turn defense visibility into partnerships, channel agreements, or paid operator accounts, SekurVoice could become the company’s clearest revenue catalyst.

Sekur Private Data (OTCQB: SWISF) is trying to position itself around a simple but high-stakes problem: when communications fail, missions can fail. The recent Internet Stock Review article framed SekurVoice around exactly that idea, using the Russia-Ukraine war as a real-world example of why unsecured communication channels can become a battlefield liability.

For investors, the SWISF story is becoming more focused. Sekur is not trying to be another generic cybersecurity platform. It is trying to build Swiss-hosted, defense-grade secure communications tools for users that cannot afford interception, surveillance, identity exposure, or network compromise.

Market Catalyst: Secure Communications Are Becoming Mission-Critical

Secure communications are now part of the defense and cybersecurity stack. Military users, government agencies, intelligence-linked personnel, defense contractors, executives, journalists, and high-risk organizations all face threats from interception, signals exploitation, phishing, surveillance, and data leaks.

The defense market is also becoming more open to communications tools that can operate outside ordinary telecom infrastructure. The article highlights that SOF Week is expected to bring together a large special operations ecosystem, including operators, commanders, acquisition professionals, government leaders, and defense industry partners.

Two numbers make this event important for SWISF investors:

• SOF Week 2026 runs from May 18 to May 21 in Tampa, giving Sekur a near-term opportunity to demonstrate SekurVoice directly to defense and special operations audiences.
• The event is described as drawing more than 23,000 attendees from 60 nations, which gives Sekur access to the exact buyer ecosystem it is trying to reach.

This does not guarantee contracts. But for a micro-cap company like SWISF, direct exposure to procurement decision-makers and special operations buyers can matter if meetings convert into pilots, partnerships, or recurring accounts.

The Core Product: SekurVoice

SekurVoice is the center of the story. The article says SWISF will demonstrate SekurVoice at SOF Week as a solution designed for sensitive, covert, or classified-adjacent communications. Sekur’s CEO, Alain Ghiai, said the product was designed to bypass traditional telecommunications infrastructure and reduce exposure to interception, signals exploitation, and network surveillance.

• Investor data point: Sekur’s prior update said SekurVoice plans start at US$3,500/year, and management projected at least 1,000 operator accounts over 12–18 months, implying about US$3.5M of potential annual revenue if achieved.

That pricing structure matters. For OTCQB: SWISF, even a few million dollars of recurring operator revenue could be meaningful because the company’s valuation remains small relative to scaled cybersecurity peers.

Why SOF Week Matters

SOF Week is not a typical trade show for Sekur. It is a concentrated defense audience. The Internet Stock Review article says Sekur’s national security team will be present, including advisors connected to U.S. Special Operations experience, and that the company expects to meet procurement decision-makers, SOCOM leadership, acquisition officers, U.S. Special Operations Forces, and partner-nation defense components.

That is important because defense communications is a relationship-heavy and trust-heavy market. SWISF still has to prove product-market fit, but the right audience can shorten the distance between product demonstration and real buyer feedback.

The article also says Sekur has been contacted by dozens of senior executives and defense-sector technology advisors interested in learning more about its secure communication tools. For investors, the next question is whether those conversations lead to announced channel agreements or contracts.

Product Stack: Beyond One Voice Tool

Sekur’s broader offering includes SekurMail, SekurMessenger, SekurVPN, and SekurRelay. The reason this matters is that defense and government customers often need more than one tool. They may need secure command email, hardened messaging, encrypted file transfer, VPN protection, identity obfuscation, and deployment flexibility.

For SWISF, SekurRelay could be especially useful because it can support phased adoption. Large organizations rarely migrate every communication layer at once. A product that allows command-level, executive, or senior-staff deployment first could reduce friction and make early adoption more realistic.

Revenue Scenario From Operator Accounts

This is not company guidance, but a simple investor scenario using Sekur’s stated US$3,500/year starting price for SekurVoice and the previously discussed 1,000 operator account target.

Scenario	Operator Accounts	Annual Price/User	Potential Annual Revenue
Early Adoption	250	US$3,500	US$875,000
Stated Target Case	1,000	US$3,500	US$3.5M
Expanded Defense Adoption	2,500	US$3,500	US$8.75M

The math is why SWISF is worth watching. If the company can turn defense demonstrations into recurring accounts, revenue could scale from a small base. But the risk is equally clear: until paid adoption is proven, the opportunity remains speculative.

Stock Snapshot

Metric	Snapshot
Company	Sekur Private Data Ltd.
Ticker	OTCQB: SWISF
Recent referenced price	Around US$0.05 in Internet Stock Review article
Sector	Cybersecurity / secure communications
Key product	SekurVoice
Near-term event	SOF Week, May 18–21, 2026
Reported audience	23,000+ attendees from 60 nations
Main investor angle	Defense-grade secure communications for high-risk users

What Investors Should Watch

The next signals for SWISF are straightforward: SOF Week meetings, product demonstrations, announced partnerships, channel agreements, pilot programs, and paid SekurVoice accounts. Technical chart commentary can help traders track sentiment, but fundamentals will matter more if Sekur wants a durable re-rating.

Investors should also monitor dilution, cash burn, and whether the company can execute after the conference. Defense procurement cycles can be slow, and early interest does not always become revenue.

Bottom Line

Sekur’s SOF Week push gives SWISF a more concrete defense communications catalyst. SekurVoice now has a clearer audience, pricing framework, and mission-critical use case.

The opportunity is that even modest recurring operator revenue could matter at Sekur’s micro-cap scale. The risk is execution: SWISF still needs to convert interest into paid accounts, partnerships, and repeatable revenue.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• OTCQB: SWISF: recently referenced around US$0.05, with Sekur still trading as a micro-cap cybersecurity name.
• Latest catalyst: Sekur is heading to SOF Week 2026 in Tampa to demonstrate SekurVoice to special operations, defense, and acquisition audiences.
• Investor angle: if SWISF can turn defense visibility into partnerships, channel agreements, or paid operator accounts, SekurVoice could become the company’s clearest revenue catalyst.

Sekur Private Data (OTCQB: SWISF) is trying to position itself around a simple but high-stakes problem: when communications fail, missions can fail. The recent Internet Stock Review article framed SekurVoice around exactly that idea, using the Russia-Ukraine war as a real-world example of why unsecured communication channels can become a battlefield liability.

For investors, the SWISF story is becoming more focused. Sekur is not trying to be another generic cybersecurity platform. It is trying to build Swiss-hosted, defense-grade secure communications tools for users that cannot afford interception, surveillance, identity exposure, or network compromise.

Market Catalyst: Secure Communications Are Becoming Mission-Critical

Secure communications are now part of the defense and cybersecurity stack. Military users, government agencies, intelligence-linked personnel, defense contractors, executives, journalists, and high-risk organizations all face threats from interception, signals exploitation, phishing, surveillance, and data leaks.

The defense market is also becoming more open to communications tools that can operate outside ordinary telecom infrastructure. The article highlights that SOF Week is expected to bring together a large special operations ecosystem, including operators, commanders, acquisition professionals, government leaders, and defense industry partners.

Two numbers make this event important for SWISF investors:

• SOF Week 2026 runs from May 18 to May 21 in Tampa, giving Sekur a near-term opportunity to demonstrate SekurVoice directly to defense and special operations audiences.
• The event is described as drawing more than 23,000 attendees from 60 nations, which gives Sekur access to the exact buyer ecosystem it is trying to reach.

This does not guarantee contracts. But for a micro-cap company like SWISF, direct exposure to procurement decision-makers and special operations buyers can matter if meetings convert into pilots, partnerships, or recurring accounts.

The Core Product: SekurVoice

SekurVoice is the center of the story. The article says SWISF will demonstrate SekurVoice at SOF Week as a solution designed for sensitive, covert, or classified-adjacent communications. Sekur’s CEO, Alain Ghiai, said the product was designed to bypass traditional telecommunications infrastructure and reduce exposure to interception, signals exploitation, and network surveillance.

• Investor data point: Sekur’s prior update said SekurVoice plans start at US$3,500/year, and management projected at least 1,000 operator accounts over 12–18 months, implying about US$3.5M of potential annual revenue if achieved.

That pricing structure matters. For OTCQB: SWISF, even a few million dollars of recurring operator revenue could be meaningful because the company’s valuation remains small relative to scaled cybersecurity peers.

Why SOF Week Matters

SOF Week is not a typical trade show for Sekur. It is a concentrated defense audience. The Internet Stock Review article says Sekur’s national security team will be present, including advisors connected to U.S. Special Operations experience, and that the company expects to meet procurement decision-makers, SOCOM leadership, acquisition officers, U.S. Special Operations Forces, and partner-nation defense components.

That is important because defense communications is a relationship-heavy and trust-heavy market. SWISF still has to prove product-market fit, but the right audience can shorten the distance between product demonstration and real buyer feedback.

The article also says Sekur has been contacted by dozens of senior executives and defense-sector technology advisors interested in learning more about its secure communication tools. For investors, the next question is whether those conversations lead to announced channel agreements or contracts.

Product Stack: Beyond One Voice Tool

Sekur’s broader offering includes SekurMail, SekurMessenger, SekurVPN, and SekurRelay. The reason this matters is that defense and government customers often need more than one tool. They may need secure command email, hardened messaging, encrypted file transfer, VPN protection, identity obfuscation, and deployment flexibility.

For SWISF, SekurRelay could be especially useful because it can support phased adoption. Large organizations rarely migrate every communication layer at once. A product that allows command-level, executive, or senior-staff deployment first could reduce friction and make early adoption more realistic.

Revenue Scenario From Operator Accounts

This is not company guidance, but a simple investor scenario using Sekur’s stated US$3,500/year starting price for SekurVoice and the previously discussed 1,000 operator account target.

Scenario	Operator Accounts	Annual Price/User	Potential Annual Revenue
Early Adoption	250	US$3,500	US$875,000
Stated Target Case	1,000	US$3,500	US$3.5M
Expanded Defense Adoption	2,500	US$3,500	US$8.75M

The math is why SWISF is worth watching. If the company can turn defense demonstrations into recurring accounts, revenue could scale from a small base. But the risk is equally clear: until paid adoption is proven, the opportunity remains speculative.

Stock Snapshot

Metric	Snapshot
Company	Sekur Private Data Ltd.
Ticker	OTCQB: SWISF
Recent referenced price	Around US$0.05 in Internet Stock Review article
Sector	Cybersecurity / secure communications
Key product	SekurVoice
Near-term event	SOF Week, May 18–21, 2026
Reported audience	23,000+ attendees from 60 nations
Main investor angle	Defense-grade secure communications for high-risk users

What Investors Should Watch

The next signals for SWISF are straightforward: SOF Week meetings, product demonstrations, announced partnerships, channel agreements, pilot programs, and paid SekurVoice accounts. Technical chart commentary can help traders track sentiment, but fundamentals will matter more if Sekur wants a durable re-rating.

Investors should also monitor dilution, cash burn, and whether the company can execute after the conference. Defense procurement cycles can be slow, and early interest does not always become revenue.

Bottom Line

Sekur’s SOF Week push gives SWISF a more concrete defense communications catalyst. SekurVoice now has a clearer audience, pricing framework, and mission-critical use case.

The opportunity is that even modest recurring operator revenue could matter at Sekur’s micro-cap scale. The risk is execution: SWISF still needs to convert interest into paid accounts, partnerships, and repeatable revenue.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• OTCQB: SWISF: recently referenced around US$0.05, with Sekur still trading as a micro-cap cybersecurity name.
• Latest catalyst: Sekur is heading to SOF Week 2026 in Tampa to demonstrate SekurVoice to special operations, defense, and acquisition audiences.
• Investor angle: if SWISF can turn defense visibility into partnerships, channel agreements, or paid operator accounts, SekurVoice could become the company’s clearest revenue catalyst.

Sekur Private Data (OTCQB: SWISF) is trying to position itself around a simple but high-stakes problem: when communications fail, missions can fail. The recent Internet Stock Review article framed SekurVoice around exactly that idea, using the Russia-Ukraine war as a real-world example of why unsecured communication channels can become a battlefield liability.

For investors, the SWISF story is becoming more focused. Sekur is not trying to be another generic cybersecurity platform. It is trying to build Swiss-hosted, defense-grade secure communications tools for users that cannot afford interception, surveillance, identity exposure, or network compromise.

Market Catalyst: Secure Communications Are Becoming Mission-Critical

Secure communications are now part of the defense and cybersecurity stack. Military users, government agencies, intelligence-linked personnel, defense contractors, executives, journalists, and high-risk organizations all face threats from interception, signals exploitation, phishing, surveillance, and data leaks.

The defense market is also becoming more open to communications tools that can operate outside ordinary telecom infrastructure. The article highlights that SOF Week is expected to bring together a large special operations ecosystem, including operators, commanders, acquisition professionals, government leaders, and defense industry partners.

Two numbers make this event important for SWISF investors:

• SOF Week 2026 runs from May 18 to May 21 in Tampa, giving Sekur a near-term opportunity to demonstrate SekurVoice directly to defense and special operations audiences.
• The event is described as drawing more than 23,000 attendees from 60 nations, which gives Sekur access to the exact buyer ecosystem it is trying to reach.

This does not guarantee contracts. But for a micro-cap company like SWISF, direct exposure to procurement decision-makers and special operations buyers can matter if meetings convert into pilots, partnerships, or recurring accounts.

The Core Product: SekurVoice

SekurVoice is the center of the story. The article says SWISF will demonstrate SekurVoice at SOF Week as a solution designed for sensitive, covert, or classified-adjacent communications. Sekur’s CEO, Alain Ghiai, said the product was designed to bypass traditional telecommunications infrastructure and reduce exposure to interception, signals exploitation, and network surveillance.

• Investor data point: Sekur’s prior update said SekurVoice plans start at US$3,500/year, and management projected at least 1,000 operator accounts over 12–18 months, implying about US$3.5M of potential annual revenue if achieved.

That pricing structure matters. For OTCQB: SWISF, even a few million dollars of recurring operator revenue could be meaningful because the company’s valuation remains small relative to scaled cybersecurity peers.

Why SOF Week Matters

SOF Week is not a typical trade show for Sekur. It is a concentrated defense audience. The Internet Stock Review article says Sekur’s national security team will be present, including advisors connected to U.S. Special Operations experience, and that the company expects to meet procurement decision-makers, SOCOM leadership, acquisition officers, U.S. Special Operations Forces, and partner-nation defense components.

That is important because defense communications is a relationship-heavy and trust-heavy market. SWISF still has to prove product-market fit, but the right audience can shorten the distance between product demonstration and real buyer feedback.

The article also says Sekur has been contacted by dozens of senior executives and defense-sector technology advisors interested in learning more about its secure communication tools. For investors, the next question is whether those conversations lead to announced channel agreements or contracts.

Product Stack: Beyond One Voice Tool

Sekur’s broader offering includes SekurMail, SekurMessenger, SekurVPN, and SekurRelay. The reason this matters is that defense and government customers often need more than one tool. They may need secure command email, hardened messaging, encrypted file transfer, VPN protection, identity obfuscation, and deployment flexibility.

For SWISF, SekurRelay could be especially useful because it can support phased adoption. Large organizations rarely migrate every communication layer at once. A product that allows command-level, executive, or senior-staff deployment first could reduce friction and make early adoption more realistic.

Revenue Scenario From Operator Accounts

This is not company guidance, but a simple investor scenario using Sekur’s stated US$3,500/year starting price for SekurVoice and the previously discussed 1,000 operator account target.

Scenario	Operator Accounts	Annual Price/User	Potential Annual Revenue
Early Adoption	250	US$3,500	US$875,000
Stated Target Case	1,000	US$3,500	US$3.5M
Expanded Defense Adoption	2,500	US$3,500	US$8.75M

The math is why SWISF is worth watching. If the company can turn defense demonstrations into recurring accounts, revenue could scale from a small base. But the risk is equally clear: until paid adoption is proven, the opportunity remains speculative.

Stock Snapshot

Metric	Snapshot
Company	Sekur Private Data Ltd.
Ticker	OTCQB: SWISF
Recent referenced price	Around US$0.05 in Internet Stock Review article
Sector	Cybersecurity / secure communications
Key product	SekurVoice
Near-term event	SOF Week, May 18–21, 2026
Reported audience	23,000+ attendees from 60 nations
Main investor angle	Defense-grade secure communications for high-risk users

What Investors Should Watch

The next signals for SWISF are straightforward: SOF Week meetings, product demonstrations, announced partnerships, channel agreements, pilot programs, and paid SekurVoice accounts. Technical chart commentary can help traders track sentiment, but fundamentals will matter more if Sekur wants a durable re-rating.

Investors should also monitor dilution, cash burn, and whether the company can execute after the conference. Defense procurement cycles can be slow, and early interest does not always become revenue.

Bottom Line

Sekur’s SOF Week push gives SWISF a more concrete defense communications catalyst. SekurVoice now has a clearer audience, pricing framework, and mission-critical use case.

The opportunity is that even modest recurring operator revenue could matter at Sekur’s micro-cap scale. The risk is execution: SWISF still needs to convert interest into paid accounts, partnerships, and repeatable revenue.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Copper Quest focus: Copper Quest Exploration Inc. (CSE: CQX / OTCQB: IMIMF / FRA: 3MX) recently traded around CA$0.09, with market cap near CA$10.9M.
• Sector catalyst: S&P Global projects copper demand rising from 28M metric tons in 2025 to 42M by 2040, while the IEA warns of a potential 30% copper supply shortfall by 2035.
• Investor angle: Copper Quest is the speculative micro-cap explorer in this basket, while Taseko, Capstone, Hudbay, and Trilogy offer larger copper production or development exposure.

Copper is becoming one of the most important metals in the market because it sits at the center of electrification, grid upgrades, AI data centers, electric vehicles, renewable energy, industrial automation, and defense infrastructure. It is not just a construction metal anymore. Copper is increasingly being treated as a strategic input for the next phase of global infrastructure.

For investors, the copper trade is not only about today’s spot price. The more important question is which companies have leverage to a tightening copper market, enough project quality to matter, and a realistic path to value creation. That is why this watchlist combines one micro-cap explorer, Copper Quest Exploration (CQX / IMIMF), with four larger copper-linked names: Taseko Mines, Capstone Copper, Hudbay Minerals, and Trilogy Metals.

Market Catalyst: Copper Demand Is Rising Faster Than New Supply

The long-term copper thesis is built on a simple problem: demand is rising, but new supply is difficult to bring online. Large copper mines can take more than a decade to permit, finance, and build. At the same time, many older mines are facing declining grades, rising capital costs, water constraints, and political risk.

The numbers explain why investors keep coming back to the copper theme:

• S&P Global projects global copper demand rising from 28M metric tons in 2025 to 42M metric tons by 2040, a roughly 50% increase driven by electrification, AI data centers, power grids, EVs, defense, and industrial demand.
• The IEA has warned that the current copper mine project pipeline could fall around 30% short of projected 2035 demand, making exploration and development assets more important if the supply gap widens.

That backdrop does not make every copper stock attractive automatically. Producers still face cost inflation and operational risk, developers still need funding and permits, and explorers still need drill results. But it does create a stronger environment for companies with real copper exposure and credible project catalysts.

1. Copper Quest Exploration: The Micro-Cap Discovery Angle

Copper Quest Exploration Inc. (CSE: CQX / OTCQB: IMIMF / FRA: 3MX) is the smallest and most speculative name in this copper basket. The company is focused on copper, molybdenum, and gold exploration across North America, with a portfolio that includes Rip, STARS, Kitimat, Alpine, Auxer, Nekash, Stellar, and Thane.

The near-term catalyst is the Rip Copper-Molybdenum Project in British Columbia. Copper Quest recently commenced a minimum 2,000-metre drill program at Rip, targeting two porphyry Cu-Mo mineralized centres identified through geophysics, airborne magnetics, and 3D induced polarization work.

• Investor data point: CQX has roughly 118.4M issued shares, about 54.2M reserved for issuance, and a market cap near CA$10.9M, giving it higher risk but more torque if drilling strengthens the Rip discovery thesis.

The broader portfolio also matters. Copper Quest says its North American critical-mineral land package includes 8 projects spanning more than 46,000 hectares. That gives IMIMF several possible news-flow channels, but the stock still depends heavily on drill results, financing discipline, and whether the company can turn targets into meaningful mineralized zones.

2. Taseko Mines: Producing Copper Exposure

Taseko Mines (NYSE American: TGB / TSX: TKO) gives investors more direct copper exposure through production and development assets. Unlike Copper Quest, Taseko is not only an exploration story. It owns the Gibraltar mine in British Columbia and has development upside through Florence Copper in Arizona.

Recent market data showed TGB trading in the US$6.90–US$7.40 range, with market cap around US$2.5B–US$2.7B. Taseko is useful in this basket because it gives investors a producing copper name with exposure to higher copper prices and project expansion.

• Investor data point: Taseko’s Gibraltar operation produced 98M pounds of copper and 1.9M pounds of molybdenum in 2025, giving TGB real operating leverage to copper prices.

The attraction is that Taseko offers production, cash-flow potential, and Florence Copper optionality. The risk is that producers remain exposed to operating costs, copper-price volatility, permitting, capex, and project execution.

3. Capstone Copper: Mid-Cap Copper Scale

Capstone Copper (TSX: CS) is a larger copper producer with operations across the Americas. It gives investors more scale than a junior explorer, while still offering more copper sensitivity than diversified mining giants.

Recent market data showed CS trading around CA$12–CA$13, with market cap around CA$9B–CA$10B. Capstone is one of the cleaner mid-cap copper producer comparisons because it already has a meaningful revenue base and operating leverage to copper prices.

• Investor data point: Capstone’s trailing revenue has been reported around US$3.46B, with strong growth from copper operations and expansion projects.

For investors, the appeal is scale and torque. Capstone can benefit directly from higher realized copper prices, but the stock already reflects part of the copper bull case. Execution, costs, production growth, and balance-sheet discipline remain key watch items.

4. Hudbay Minerals: Copper Growth and M&A Leverage

Hudbay Minerals (NYSE: HBM / TSX: HBM) is another closely watched copper-linked miner. The company has copper exposure through existing operations and has been expanding its U.S. copper strategy, including the proposed acquisition of Arizona Sonoran Copper Company.

Recent market data showed HBM trading around US$24–US$25, with market cap near US$9B–US$10B. Hudbay has already had a strong move, but it remains relevant because it combines production exposure, earnings leverage, and growth through copper-focused M&A.

• Investor data point: Recent updates showed HBM posted roughly 67% EPS growth and 27% sales growth, while the Arizona Sonoran deal was valued around US$1.48B.

Hudbay’s appeal is that it gives investors a more mature copper growth story. The risk is that M&A brings integration risk, project risk, and valuation risk if copper prices cool or growth expectations move too far ahead of fundamentals.

5. Trilogy Metals: High-Beta Copper Development

Trilogy Metals (NYSE American: TMQ / TSX: TMQ) is a development-stage copper name focused on Alaska’s Ambler Mining District. It is not a producer, which makes the stock more sensitive to permitting, project updates, strategic interest, and investor appetite for future copper supply.

Recent market data showed TMQ trading around US$4.40–US$6.10, with market cap in the US$780M–US$870M range. The stock’s wide trading range shows how volatile copper development stories can be when sentiment shifts.

• Investor data point: TMQ has traded in a wide 52-week range of roughly US$1.13–US$11.29, highlighting both the upside torque and downside volatility of pre-production copper development stocks.

Trilogy is useful as a comparison for CQX because it shows how the market can assign much larger valuations to copper assets once project scale becomes more defined. The risk is that development-stage projects require time, capital, permitting success, infrastructure, and strong commodity conditions.

Stock Snapshot

https://preview.redd.it/14bqeyq0no2h1.png?width=1538&format=png&auto=webp&s=acd634b8a4952ae46811237aa5e5cbfe8c282da8

Bottom Line

Copper Quest is the speculative micro-cap in this copper basket. CQX / IMIMF has a defined drill catalyst at Rip, a broader 46,000-hectare North American critical-minerals portfolio, and exposure to a copper market where demand could rise 50% by 2040.

The larger names offer different risk profiles: TGB for production and Florence Copper, CS for mid-cap scale, HBM for copper growth and M&A, and TMQ for high-beta development exposure. For CQX, the next proof points are simple: drill results, follow-up targets, financing discipline, and whether Rip can become a more credible copper-moly discovery story.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Copper Quest focus: Copper Quest Exploration Inc. (CSE: CQX / OTCQB: IMIMF / FRA: 3MX) recently traded around CA$0.09, with market cap near CA$10.9M.
• Sector catalyst: S&P Global projects copper demand rising from 28M metric tons in 2025 to 42M by 2040, while the IEA warns of a potential 30% copper supply shortfall by 2035.
• Investor angle: Copper Quest is the speculative micro-cap explorer in this basket, while Taseko, Capstone, Hudbay, and Trilogy offer larger copper production or development exposure.

Copper is becoming one of the most important metals in the market because it sits at the center of electrification, grid upgrades, AI data centers, electric vehicles, renewable energy, industrial automation, and defense infrastructure. It is not just a construction metal anymore. Copper is increasingly being treated as a strategic input for the next phase of global infrastructure.

For investors, the copper trade is not only about today’s spot price. The more important question is which companies have leverage to a tightening copper market, enough project quality to matter, and a realistic path to value creation. That is why this watchlist combines one micro-cap explorer, Copper Quest Exploration (CQX / IMIMF), with four larger copper-linked names: Taseko Mines, Capstone Copper, Hudbay Minerals, and Trilogy Metals.

Market Catalyst: Copper Demand Is Rising Faster Than New Supply

The long-term copper thesis is built on a simple problem: demand is rising, but new supply is difficult to bring online. Large copper mines can take more than a decade to permit, finance, and build. At the same time, many older mines are facing declining grades, rising capital costs, water constraints, and political risk.

The numbers explain why investors keep coming back to the copper theme:

• S&P Global projects global copper demand rising from 28M metric tons in 2025 to 42M metric tons by 2040, a roughly 50% increase driven by electrification, AI data centers, power grids, EVs, defense, and industrial demand.
• The IEA has warned that the current copper mine project pipeline could fall around 30% short of projected 2035 demand, making exploration and development assets more important if the supply gap widens.

That backdrop does not make every copper stock attractive automatically. Producers still face cost inflation and operational risk, developers still need funding and permits, and explorers still need drill results. But it does create a stronger environment for companies with real copper exposure and credible project catalysts.

1. Copper Quest Exploration: The Micro-Cap Discovery Angle

Copper Quest Exploration Inc. (CSE: CQX / OTCQB: IMIMF / FRA: 3MX) is the smallest and most speculative name in this copper basket. The company is focused on copper, molybdenum, and gold exploration across North America, with a portfolio that includes Rip, STARS, Kitimat, Alpine, Auxer, Nekash, Stellar, and Thane.

The near-term catalyst is the Rip Copper-Molybdenum Project in British Columbia. Copper Quest recently commenced a minimum 2,000-metre drill program at Rip, targeting two porphyry Cu-Mo mineralized centres identified through geophysics, airborne magnetics, and 3D induced polarization work.

• Investor data point: CQX has roughly 118.4M issued shares, about 54.2M reserved for issuance, and a market cap near CA$10.9M, giving it higher risk but more torque if drilling strengthens the Rip discovery thesis.

The broader portfolio also matters. Copper Quest says its North American critical-mineral land package includes 8 projects spanning more than 46,000 hectares. That gives IMIMF several possible news-flow channels, but the stock still depends heavily on drill results, financing discipline, and whether the company can turn targets into meaningful mineralized zones.

2. Taseko Mines: Producing Copper Exposure

Taseko Mines (NYSE American: TGB / TSX: TKO) gives investors more direct copper exposure through production and development assets. Unlike Copper Quest, Taseko is not only an exploration story. It owns the Gibraltar mine in British Columbia and has development upside through Florence Copper in Arizona.

Recent market data showed TGB trading in the US$6.90–US$7.40 range, with market cap around US$2.5B–US$2.7B. Taseko is useful in this basket because it gives investors a producing copper name with exposure to higher copper prices and project expansion.

• Investor data point: Taseko’s Gibraltar operation produced 98M pounds of copper and 1.9M pounds of molybdenum in 2025, giving TGB real operating leverage to copper prices.

The attraction is that Taseko offers production, cash-flow potential, and Florence Copper optionality. The risk is that producers remain exposed to operating costs, copper-price volatility, permitting, capex, and project execution.

3. Capstone Copper: Mid-Cap Copper Scale

Capstone Copper (TSX: CS) is a larger copper producer with operations across the Americas. It gives investors more scale than a junior explorer, while still offering more copper sensitivity than diversified mining giants.

Recent market data showed CS trading around CA$12–CA$13, with market cap around CA$9B–CA$10B. Capstone is one of the cleaner mid-cap copper producer comparisons because it already has a meaningful revenue base and operating leverage to copper prices.

• Investor data point: Capstone’s trailing revenue has been reported around US$3.46B, with strong growth from copper operations and expansion projects.

For investors, the appeal is scale and torque. Capstone can benefit directly from higher realized copper prices, but the stock already reflects part of the copper bull case. Execution, costs, production growth, and balance-sheet discipline remain key watch items.

4. Hudbay Minerals: Copper Growth and M&A Leverage

Hudbay Minerals (NYSE: HBM / TSX: HBM) is another closely watched copper-linked miner. The company has copper exposure through existing operations and has been expanding its U.S. copper strategy, including the proposed acquisition of Arizona Sonoran Copper Company.

Recent market data showed HBM trading around US$24–US$25, with market cap near US$9B–US$10B. Hudbay has already had a strong move, but it remains relevant because it combines production exposure, earnings leverage, and growth through copper-focused M&A.

• Investor data point: Recent updates showed HBM posted roughly 67% EPS growth and 27% sales growth, while the Arizona Sonoran deal was valued around US$1.48B.

Hudbay’s appeal is that it gives investors a more mature copper growth story. The risk is that M&A brings integration risk, project risk, and valuation risk if copper prices cool or growth expectations move too far ahead of fundamentals.

5. Trilogy Metals: High-Beta Copper Development

Trilogy Metals (NYSE American: TMQ / TSX: TMQ) is a development-stage copper name focused on Alaska’s Ambler Mining District. It is not a producer, which makes the stock more sensitive to permitting, project updates, strategic interest, and investor appetite for future copper supply.

Recent market data showed TMQ trading around US$4.40–US$6.10, with market cap in the US$780M–US$870M range. The stock’s wide trading range shows how volatile copper development stories can be when sentiment shifts.

• Investor data point: TMQ has traded in a wide 52-week range of roughly US$1.13–US$11.29, highlighting both the upside torque and downside volatility of pre-production copper development stocks.

Trilogy is useful as a comparison for CQX because it shows how the market can assign much larger valuations to copper assets once project scale becomes more defined. The risk is that development-stage projects require time, capital, permitting success, infrastructure, and strong commodity conditions.

Stock Snapshot

Company	Ticker	Recent Price	Market Cap	Latest Key Number	Main Copper Angle
Copper Quest Exploration	CSE: CQX / OTCQB: IMIMF	~CA$0.09	~CA$10.9M	2,000-metre Rip drill program	Micro-cap copper-moly exploration
Taseko Mines	NYSE American: TGB / TSX: TKO	~US$6.90–US$7.40	~US$2.5B–US$2.7B	98M lb copper produced in 2025	Copper production and Florence Copper upside
Capstone Copper	TSX: CS	~CA$12–CA$13	~CA$9B–CA$10B	Revenue around US$3.46B	Mid-cap copper producer leverage
Hudbay Minerals	NYSE: HBM / TSX: HBM	~US$24–US$25	~US$9B–US$10B	EPS +67%, sales +27% in recent quarter	Producer growth and U.S. copper M&A
Trilogy Metals	NYSE American: TMQ / TSX: TMQ	~US$4.40–US$6.10	~US$780M–US$870M	52-week range: US$1.13–US$11.29	High-beta copper development

Bottom Line

Copper Quest is the speculative micro-cap in this copper basket. CQX / IMIMF has a defined drill catalyst at Rip, a broader 46,000-hectare North American critical-minerals portfolio, and exposure to a copper market where demand could rise 50% by 2040.

The larger names offer different risk profiles: TGB for production and Florence Copper, CS for mid-cap scale, HBM for copper growth and M&A, and TMQ for high-beta development exposure. For CQX, the next proof points are simple: drill results, follow-up targets, financing discipline, and whether Rip can become a more credible copper-moly discovery story.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Copper Quest focus: Copper Quest Exploration Inc. (CSE: CQX / OTCQB: IMIMF / FRA: 3MX) recently traded around CA$0.09, with market cap near CA$10.9M.
• Sector catalyst: S&P Global projects copper demand rising from 28M metric tons in 2025 to 42M by 2040, while the IEA warns of a potential 30% copper supply shortfall by 2035.
• Investor angle: Copper Quest is the speculative micro-cap explorer in this basket, while Taseko, Capstone, Hudbay, and Trilogy offer larger copper production or development exposure.

Copper is becoming one of the most important metals in the market because it sits at the center of electrification, grid upgrades, AI data centers, electric vehicles, renewable energy, industrial automation, and defense infrastructure. It is not just a construction metal anymore. Copper is increasingly being treated as a strategic input for the next phase of global infrastructure.

For investors, the copper trade is not only about today’s spot price. The more important question is which companies have leverage to a tightening copper market, enough project quality to matter, and a realistic path to value creation. That is why this watchlist combines one micro-cap explorer, Copper Quest Exploration (CQX / IMIMF), with four larger copper-linked names: Taseko Mines, Capstone Copper, Hudbay Minerals, and Trilogy Metals.

Market Catalyst: Copper Demand Is Rising Faster Than New Supply

The long-term copper thesis is built on a simple problem: demand is rising, but new supply is difficult to bring online. Large copper mines can take more than a decade to permit, finance, and build. At the same time, many older mines are facing declining grades, rising capital costs, water constraints, and political risk.

The numbers explain why investors keep coming back to the copper theme:

• S&P Global projects global copper demand rising from 28M metric tons in 2025 to 42M metric tons by 2040, a roughly 50% increase driven by electrification, AI data centers, power grids, EVs, defense, and industrial demand.
• The IEA has warned that the current copper mine project pipeline could fall around 30% short of projected 2035 demand, making exploration and development assets more important if the supply gap widens.

That backdrop does not make every copper stock attractive automatically. Producers still face cost inflation and operational risk, developers still need funding and permits, and explorers still need drill results. But it does create a stronger environment for companies with real copper exposure and credible project catalysts.

1. Copper Quest Exploration: The Micro-Cap Discovery Angle

Copper Quest Exploration Inc. (CSE: CQX / OTCQB: IMIMF / FRA: 3MX) is the smallest and most speculative name in this copper basket. The company is focused on copper, molybdenum, and gold exploration across North America, with a portfolio that includes Rip, STARS, Kitimat, Alpine, Auxer, Nekash, Stellar, and Thane.

The near-term catalyst is the Rip Copper-Molybdenum Project in British Columbia. Copper Quest recently commenced a minimum 2,000-metre drill program at Rip, targeting two porphyry Cu-Mo mineralized centres identified through geophysics, airborne magnetics, and 3D induced polarization work.

• Investor data point: CQX has roughly 118.4M issued shares, about 54.2M reserved for issuance, and a market cap near CA$10.9M, giving it higher risk but more torque if drilling strengthens the Rip discovery thesis.

The broader portfolio also matters. Copper Quest says its North American critical-mineral land package includes 8 projects spanning more than 46,000 hectares. That gives IMIMF several possible news-flow channels, but the stock still depends heavily on drill results, financing discipline, and whether the company can turn targets into meaningful mineralized zones.

2. Taseko Mines: Producing Copper Exposure

Taseko Mines (NYSE American: TGB / TSX: TKO) gives investors more direct copper exposure through production and development assets. Unlike Copper Quest, Taseko is not only an exploration story. It owns the Gibraltar mine in British Columbia and has development upside through Florence Copper in Arizona.

Recent market data showed TGB trading in the US$6.90–US$7.40 range, with market cap around US$2.5B–US$2.7B. Taseko is useful in this basket because it gives investors a producing copper name with exposure to higher copper prices and project expansion.

• Investor data point: Taseko’s Gibraltar operation produced 98M pounds of copper and 1.9M pounds of molybdenum in 2025, giving TGB real operating leverage to copper prices.

The attraction is that Taseko offers production, cash-flow potential, and Florence Copper optionality. The risk is that producers remain exposed to operating costs, copper-price volatility, permitting, capex, and project execution.

3. Capstone Copper: Mid-Cap Copper Scale

Capstone Copper (TSX: CS) is a larger copper producer with operations across the Americas. It gives investors more scale than a junior explorer, while still offering more copper sensitivity than diversified mining giants.

Recent market data showed CS trading around CA$12–CA$13, with market cap around CA$9B–CA$10B. Capstone is one of the cleaner mid-cap copper producer comparisons because it already has a meaningful revenue base and operating leverage to copper prices.

• Investor data point: Capstone’s trailing revenue has been reported around US$3.46B, with strong growth from copper operations and expansion projects.

For investors, the appeal is scale and torque. Capstone can benefit directly from higher realized copper prices, but the stock already reflects part of the copper bull case. Execution, costs, production growth, and balance-sheet discipline remain key watch items.

4. Hudbay Minerals: Copper Growth and M&A Leverage

Hudbay Minerals (NYSE: HBM / TSX: HBM) is another closely watched copper-linked miner. The company has copper exposure through existing operations and has been expanding its U.S. copper strategy, including the proposed acquisition of Arizona Sonoran Copper Company.

Recent market data showed HBM trading around US$24–US$25, with market cap near US$9B–US$10B. Hudbay has already had a strong move, but it remains relevant because it combines production exposure, earnings leverage, and growth through copper-focused M&A.

• Investor data point: Recent updates showed HBM posted roughly 67% EPS growth and 27% sales growth, while the Arizona Sonoran deal was valued around US$1.48B.

Hudbay’s appeal is that it gives investors a more mature copper growth story. The risk is that M&A brings integration risk, project risk, and valuation risk if copper prices cool or growth expectations move too far ahead of fundamentals.

5. Trilogy Metals: High-Beta Copper Development

Trilogy Metals (NYSE American: TMQ / TSX: TMQ) is a development-stage copper name focused on Alaska’s Ambler Mining District. It is not a producer, which makes the stock more sensitive to permitting, project updates, strategic interest, and investor appetite for future copper supply.

Recent market data showed TMQ trading around US$4.40–US$6.10, with market cap in the US$780M–US$870M range. The stock’s wide trading range shows how volatile copper development stories can be when sentiment shifts.

• Investor data point: TMQ has traded in a wide 52-week range of roughly US$1.13–US$11.29, highlighting both the upside torque and downside volatility of pre-production copper development stocks.

Trilogy is useful as a comparison for CQX because it shows how the market can assign much larger valuations to copper assets once project scale becomes more defined. The risk is that development-stage projects require time, capital, permitting success, infrastructure, and strong commodity conditions.

Stock Snapshot

https://preview.redd.it/yojxam9gmo2h1.png?width=1538&format=png&auto=webp&s=6720168680b7243086347e82e38d0ae5af8d6df1

Bottom Line

Copper Quest is the speculative micro-cap in this copper basket. CQX / IMIMF has a defined drill catalyst at Rip, a broader 46,000-hectare North American critical-minerals portfolio, and exposure to a copper market where demand could rise 50% by 2040.

The larger names offer different risk profiles: TGB for production and Florence Copper, CS for mid-cap scale, HBM for copper growth and M&A, and TMQ for high-beta development exposure. For CQX, the next proof points are simple: drill results, follow-up targets, financing discipline, and whether Rip can become a more credible copper-moly discovery story.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Copper Quest focus: Copper Quest Exploration Inc. (CSE: CQX / OTCQB: IMIMF / FRA: 3MX) recently traded around CA$0.09, with market cap near CA$10.9M.
• Sector catalyst: S&P Global projects copper demand rising from 28M metric tons in 2025 to 42M by 2040, while the IEA warns of a potential 30% copper supply shortfall by 2035.
• Investor angle: Copper Quest is the speculative micro-cap explorer in this basket, while Taseko, Capstone, Hudbay, and Trilogy offer larger copper production or development exposure.

Copper is becoming one of the most important metals in the market because it sits at the center of electrification, grid upgrades, AI data centers, electric vehicles, renewable energy, industrial automation, and defense infrastructure. It is not just a construction metal anymore. Copper is increasingly being treated as a strategic input for the next phase of global infrastructure.

For investors, the copper trade is not only about today’s spot price. The more important question is which companies have leverage to a tightening copper market, enough project quality to matter, and a realistic path to value creation. That is why this watchlist combines one micro-cap explorer, Copper Quest Exploration (CQX / IMIMF), with four larger copper-linked names: Taseko Mines, Capstone Copper, Hudbay Minerals, and Trilogy Metals.

Market Catalyst: Copper Demand Is Rising Faster Than New Supply

The long-term copper thesis is built on a simple problem: demand is rising, but new supply is difficult to bring online. Large copper mines can take more than a decade to permit, finance, and build. At the same time, many older mines are facing declining grades, rising capital costs, water constraints, and political risk.

The numbers explain why investors keep coming back to the copper theme:

• S&P Global projects global copper demand rising from 28M metric tons in 2025 to 42M metric tons by 2040, a roughly 50% increase driven by electrification, AI data centers, power grids, EVs, defense, and industrial demand.
• The IEA has warned that the current copper mine project pipeline could fall around 30% short of projected 2035 demand, making exploration and development assets more important if the supply gap widens.

That backdrop does not make every copper stock attractive automatically. Producers still face cost inflation and operational risk, developers still need funding and permits, and explorers still need drill results. But it does create a stronger environment for companies with real copper exposure and credible project catalysts.

1. Copper Quest Exploration: The Micro-Cap Discovery Angle

Copper Quest Exploration Inc. (CSE: CQX / OTCQB: IMIMF / FRA: 3MX) is the smallest and most speculative name in this copper basket. The company is focused on copper, molybdenum, and gold exploration across North America, with a portfolio that includes Rip, STARS, Kitimat, Alpine, Auxer, Nekash, Stellar, and Thane.

The near-term catalyst is the Rip Copper-Molybdenum Project in British Columbia. Copper Quest recently commenced a minimum 2,000-metre drill program at Rip, targeting two porphyry Cu-Mo mineralized centres identified through geophysics, airborne magnetics, and 3D induced polarization work.

• Investor data point: CQX has roughly 118.4M issued shares, about 54.2M reserved for issuance, and a market cap near CA$10.9M, giving it higher risk but more torque if drilling strengthens the Rip discovery thesis.

The broader portfolio also matters. Copper Quest says its North American critical-mineral land package includes 8 projects spanning more than 46,000 hectares. That gives IMIMF several possible news-flow channels, but the stock still depends heavily on drill results, financing discipline, and whether the company can turn targets into meaningful mineralized zones.

2. Taseko Mines: Producing Copper Exposure

Taseko Mines (NYSE American: TGB / TSX: TKO) gives investors more direct copper exposure through production and development assets. Unlike Copper Quest, Taseko is not only an exploration story. It owns the Gibraltar mine in British Columbia and has development upside through Florence Copper in Arizona.

Recent market data showed TGB trading in the US$6.90–US$7.40 range, with market cap around US$2.5B–US$2.7B. Taseko is useful in this basket because it gives investors a producing copper name with exposure to higher copper prices and project expansion.

• Investor data point: Taseko’s Gibraltar operation produced 98M pounds of copper and 1.9M pounds of molybdenum in 2025, giving TGB real operating leverage to copper prices.

The attraction is that Taseko offers production, cash-flow potential, and Florence Copper optionality. The risk is that producers remain exposed to operating costs, copper-price volatility, permitting, capex, and project execution.

3. Capstone Copper: Mid-Cap Copper Scale

Capstone Copper (TSX: CS) is a larger copper producer with operations across the Americas. It gives investors more scale than a junior explorer, while still offering more copper sensitivity than diversified mining giants.

Recent market data showed CS trading around CA$12–CA$13, with market cap around CA$9B–CA$10B. Capstone is one of the cleaner mid-cap copper producer comparisons because it already has a meaningful revenue base and operating leverage to copper prices.

• Investor data point: Capstone’s trailing revenue has been reported around US$3.46B, with strong growth from copper operations and expansion projects.

For investors, the appeal is scale and torque. Capstone can benefit directly from higher realized copper prices, but the stock already reflects part of the copper bull case. Execution, costs, production growth, and balance-sheet discipline remain key watch items.

4. Hudbay Minerals: Copper Growth and M&A Leverage

Hudbay Minerals (NYSE: HBM / TSX: HBM) is another closely watched copper-linked miner. The company has copper exposure through existing operations and has been expanding its U.S. copper strategy, including the proposed acquisition of Arizona Sonoran Copper Company.

Recent market data showed HBM trading around US$24–US$25, with market cap near US$9B–US$10B. Hudbay has already had a strong move, but it remains relevant because it combines production exposure, earnings leverage, and growth through copper-focused M&A.

• Investor data point: Recent updates showed HBM posted roughly 67% EPS growth and 27% sales growth, while the Arizona Sonoran deal was valued around US$1.48B.

Hudbay’s appeal is that it gives investors a more mature copper growth story. The risk is that M&A brings integration risk, project risk, and valuation risk if copper prices cool or growth expectations move too far ahead of fundamentals.

5. Trilogy Metals: High-Beta Copper Development

Trilogy Metals (NYSE American: TMQ / TSX: TMQ) is a development-stage copper name focused on Alaska’s Ambler Mining District. It is not a producer, which makes the stock more sensitive to permitting, project updates, strategic interest, and investor appetite for future copper supply.

Recent market data showed TMQ trading around US$4.40–US$6.10, with market cap in the US$780M–US$870M range. The stock’s wide trading range shows how volatile copper development stories can be when sentiment shifts.

• Investor data point: TMQ has traded in a wide 52-week range of roughly US$1.13–US$11.29, highlighting both the upside torque and downside volatility of pre-production copper development stocks.

Trilogy is useful as a comparison for CQX because it shows how the market can assign much larger valuations to copper assets once project scale becomes more defined. The risk is that development-stage projects require time, capital, permitting success, infrastructure, and strong commodity conditions.

Stock Snapshot

https://preview.redd.it/ovp2buwzlo2h1.png?width=1538&format=png&auto=webp&s=c68dfb5f95145f247151d7bbef2ebd59ff8aa0e1

Bottom Line

Copper Quest is the speculative micro-cap in this copper basket. CQX / IMIMF has a defined drill catalyst at Rip, a broader 46,000-hectare North American critical-minerals portfolio, and exposure to a copper market where demand could rise 50% by 2040.

The larger names offer different risk profiles: TGB for production and Florence Copper, CS for mid-cap scale, HBM for copper growth and M&A, and TMQ for high-beta development exposure. For CQX, the next proof points are simple: drill results, follow-up targets, financing discipline, and whether Rip can become a more credible copper-moly discovery story.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Sector catalyst: healthcare AI is moving into real clinical workflows, from ECG processing and genomics to drug discovery and portable imaging.
• Investor angle: AIML is the micro-cap ECG-AI name in this basket, while SOPH, RXRX, SDGR, and BFLY show how larger AI healthcare platforms are already building commercial scale.

AI healthcare is becoming one of the more investable areas of the artificial intelligence market because the use cases are moving closer to real clinical workflows. Hospitals, research institutes, diagnostic labs, pharma companies, and device makers are all looking for ways to process medical data faster and more accurately.

For investors, the opportunity is not just “AI in medicine.” The real question is which companies have useful data, credible clinical partners, commercial adoption, enough cash to execute, and a product that solves a measurable healthcare bottleneck. That is why this watchlist combines one speculative micro-cap, AI/ML Innovations (AIMLF), with four larger AI healthcare names: SOPHiA GENETICS, Recursion Pharmaceuticals, Schrödinger, and Butterfly Network.

Market Catalyst: AI Is Moving Into Healthcare Workflows

Healthcare AI is already appearing in ECG interpretation, Holter analysis, precision oncology, genomics, ultrasound imaging, drug discovery, clinical trial design, and hospital decision support. The sector is attractive because healthcare creates enormous volumes of data, but much of that data remains fragmented, difficult to structure, and time-consuming for clinicians to review.

The numbers explain why investors are watching the space. Grand View Research estimated the global AI healthcare market at roughly US$26.6B in 2024, with a high-growth outlook through the end of the decade. Cardiovascular disease remains one of the world’s largest healthcare burdens, responsible for roughly 17.9M deaths per year, while Holter monitoring can generate 24 hours to 14 days of continuous rhythm data per patient.

Two data points show why this matters:

• Clinical data volumes are expanding quickly: ECG, Holter, genomic, imaging, and monitoring workflows generate large datasets where automation, labeling, pattern recognition, and signal processing can reduce bottlenecks.
• Commercial adoption is already visible: SOPHiA GENETICS processed 108,000 genomic analyses in Q1 2026, while Butterfly Network generated US$26.5M of Q1 2026 revenue, up 25% year over year.

The opportunity is real, but healthcare AI is not an easy market. Companies still need clinical validation, regulatory discipline, reimbursement pathways, hospital procurement access, commercial traction, cash runway, and proof that their platforms can scale beyond pilots.

1. AI/ML Innovations: The Micro-Cap ECG-AI Angle

AI/ML Innovations Inc. (CSE: AIML / OTCQB: AIMLF) is the smallest and most speculative name in this AI healthcare basket. The company is focused on digital health and artificial intelligence, with its NeuralCloud subsidiary targeting ECG signal processing, Holter analysis, and cardiovascular-data workflows.

The core platform is MaxYield™, NeuralCloud’s ECG signal-processing technology. AIML says MaxYield™ is designed to convert raw or legacy ECG data into structured, machine-readable formats, isolate and label ECG waveform components, and generate beat-level data and interval measurements.

• Investor data point: AIMLF trades around US$0.037–US$0.040, with market cap around US$7M–US$10M and roughly 271.1M shares outstanding.

The latest credibility catalyst is AIML’s appointment of Dr. Martin Stephen Green to its Medical Advisory Board. Dr. Green brings about 45 years of ECG and Holter interpretation experience and has authored or co-authored more than 230 peer-reviewed publications. For AIMLF, this matters because ECG-AI adoption requires physician trust, not just software capability.

https://preview.redd.it/w059zbg1uh2h1.png?width=1196&format=png&auto=webp&s=f2abcb08164a42ce17b74d8ab993d6ea078ddb27

2. SOPHiA GENETICS: AI Precision Medicine at Commercial Scale

SOPHiA GENETICS (NASDAQ: SOPH) is a more mature AI healthcare company focused on data-driven medicine, especially genomics and precision oncology. Its SOPHiA DDM™ platform helps healthcare providers analyze multimodal medical data and apply AI-supported insights to clinical and research workflows.

SOPH’s Q1 2026 results showed US$21.7M in revenue, up 22% year over year. The company also reported a record 108,000 genomic analyses on the platform and 537 core genomics customers, up from 490 a year earlier.

• Investor data point: SOPH guided for full-year 2026 revenue of US$92M–US$94M, implying roughly 20%–22% growth.

SOPH is useful as a comparison for AIMLF because it shows what healthcare AI can look like when a platform gains measurable adoption across labs and hospitals. The risk is that SOPH still needs to show a clearer path toward profitability and cash-flow discipline.

https://preview.redd.it/zbplxre6uh2h1.png?width=1196&format=png&auto=webp&s=5b3680b17f320ebd487289f516d58a9144a7f35b

3. Recursion Pharmaceuticals: AI Drug Discovery With Cash Runway

Recursion Pharmaceuticals (NASDAQ: RXRX) is one of the most recognized AI drug-discovery companies. Its platform uses automation, machine learning, biological datasets, and computational tools to identify and advance drug candidates.

Recursion’s Q1 2026 update showed US$6.5M in revenue, mostly from collaboration agreements, and US$665.2M in cash, cash equivalents, and restricted cash as of March 31, 2026. The company also said its cash runway extends into early 2028 under current operating plans.

• Investor data point: RXRX’s Q1 cash operating expense was US$85.1M, showing both the scale of its platform ambitions and the capital intensity of AI drug discovery.

For investors, RXRX offers exposure to the idea that AI can improve the speed and efficiency of drug discovery. The risk is that drug development remains expensive, uncertain, and milestone-driven, even when powered by AI.

https://preview.redd.it/xpjpsyf8uh2h1.png?width=1196&format=png&auto=webp&s=c429ed8a2340fe1a7c719595fda51ff407b2c047

4. Schrödinger: Computational Drug Discovery and Software

Schrödinger (NASDAQ: SDGR) gives investors exposure to computational drug discovery, molecular modeling, and scientific software. The company combines a software platform used by life-sciences customers with a drug-discovery pipeline.

Its Q1 2026 update highlighted US$28M in first-quarter annual contract value, representing 12% growth. Schrödinger also said it plans to launch Bunsen, an agentic AI co-scientist, this summer, showing how AI is becoming more embedded in computational research workflows.

• Investor data point: SDGR’s model gives investors two revenue angles: software adoption today and longer-term upside from internally developed or partnered drug candidates.

SDGR is a reminder that AI healthcare does not always mean direct patient-facing tools. Some of the opportunity sits inside the research and discovery stack. The risk is that drug-discovery upside can take years to convert into meaningful earnings.

https://preview.redd.it/gliab58auh2h1.png?width=1196&format=png&auto=webp&s=723a4e3ab974c46c0b928d103b17a8dd39d6ab2d

5. Butterfly Network: AI-Enabled Medical Imaging

Butterfly Network (NYSE: BFLY) gives investors exposure to AI-enabled imaging and portable ultrasound. The company’s handheld ultrasound platform is designed to make imaging more accessible, portable, and software-driven.

Butterfly reported Q1 2026 revenue of US$26.5M, up 25% year over year. Gross profit was US$18.3M, and gross margin improved to 68.9%, compared with 63.0% in the prior-year period.

• Investor data point: BFLY reaffirmed full-year 2026 revenue guidance of US$117M–US$121M, giving it one of the clearer revenue bases in this AI healthcare basket.

Butterfly is useful as a comparison because it shows how AI can move into devices and diagnostics, not just software dashboards or drug-discovery platforms. The risk is that device adoption, hospital budgets, and profitability still need to improve over time.

https://preview.redd.it/hitx6tpbuh2h1.png?width=1196&format=png&auto=webp&s=5a426665f418c0583f64d1d1382f08ad6172bc23

Stock Snapshot

https://preview.redd.it/a432sxpduh2h1.png?width=1196&format=png&auto=webp&s=73ee04a3482299855122096eae5fcd5f7e42fe6f

Bottom Line

AI/ML Innovations is the speculative micro-cap in this AI healthcare basket. AIMLF has a focused ECG-AI angle, fresh clinical credibility through Dr. Martin Green, and exposure to cardiovascular-data workflows where automation could matter.

The larger names show how broad the AI healthcare theme has become: SOPH in genomics, RXRX and SDGR in drug discovery, and BFLY in medical imaging. For AIMLF, the next proof points are validation, partnerships, pilots, recurring revenue, and whether NeuralCloud’s MaxYield™ platform can move from research credibility toward commercial adoption.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Sector catalyst: healthcare AI is moving into real clinical workflows, from ECG processing and genomics to drug discovery and portable imaging.
• Investor angle: AIML is the micro-cap ECG-AI name in this basket, while SOPH, RXRX, SDGR, and BFLY show how larger AI healthcare platforms are already building commercial scale.

AI healthcare is becoming one of the more investable areas of the artificial intelligence market because the use cases are moving closer to real clinical workflows. Hospitals, research institutes, diagnostic labs, pharma companies, and device makers are all looking for ways to process medical data faster and more accurately.

For investors, the opportunity is not just “AI in medicine.” The real question is which companies have useful data, credible clinical partners, commercial adoption, enough cash to execute, and a product that solves a measurable healthcare bottleneck. That is why this watchlist combines one speculative micro-cap, AI/ML Innovations (AIMLF), with four larger AI healthcare names: SOPHiA GENETICS, Recursion Pharmaceuticals, Schrödinger, and Butterfly Network.

Market Catalyst: AI Is Moving Into Healthcare Workflows

Healthcare AI is already appearing in ECG interpretation, Holter analysis, precision oncology, genomics, ultrasound imaging, drug discovery, clinical trial design, and hospital decision support. The sector is attractive because healthcare creates enormous volumes of data, but much of that data remains fragmented, difficult to structure, and time-consuming for clinicians to review.

The numbers explain why investors are watching the space. Grand View Research estimated the global AI healthcare market at roughly US$26.6B in 2024, with a high-growth outlook through the end of the decade. Cardiovascular disease remains one of the world’s largest healthcare burdens, responsible for roughly 17.9M deaths per year, while Holter monitoring can generate 24 hours to 14 days of continuous rhythm data per patient.

Two data points show why this matters:

• Clinical data volumes are expanding quickly: ECG, Holter, genomic, imaging, and monitoring workflows generate large datasets where automation, labeling, pattern recognition, and signal processing can reduce bottlenecks.
• Commercial adoption is already visible: SOPHiA GENETICS processed 108,000 genomic analyses in Q1 2026, while Butterfly Network generated US$26.5M of Q1 2026 revenue, up 25% year over year.

The opportunity is real, but healthcare AI is not an easy market. Companies still need clinical validation, regulatory discipline, reimbursement pathways, hospital procurement access, commercial traction, cash runway, and proof that their platforms can scale beyond pilots.

1. AI/ML Innovations: The Micro-Cap ECG-AI Angle

AI/ML Innovations Inc. (CSE: AIML / OTCQB: AIMLF) is the smallest and most speculative name in this AI healthcare basket. The company is focused on digital health and artificial intelligence, with its NeuralCloud subsidiary targeting ECG signal processing, Holter analysis, and cardiovascular-data workflows.

The core platform is MaxYield™, NeuralCloud’s ECG signal-processing technology. AIML says MaxYield™ is designed to convert raw or legacy ECG data into structured, machine-readable formats, isolate and label ECG waveform components, and generate beat-level data and interval measurements.

• Investor data point: AIMLF trades around US$0.037–US$0.040, with market cap around US$7M–US$10M and roughly 271.1M shares outstanding.

The latest credibility catalyst is AIML’s appointment of Dr. Martin Stephen Green to its Medical Advisory Board. Dr. Green brings about 45 years of ECG and Holter interpretation experience and has authored or co-authored more than 230 peer-reviewed publications. For AIMLF, this matters because ECG-AI adoption requires physician trust, not just software capability.

https://preview.redd.it/7p3jhcekth2h1.png?width=1196&format=png&auto=webp&s=d74191a4610d82dab759473e465e0cc676d3dd04

2. SOPHiA GENETICS: AI Precision Medicine at Commercial Scale

SOPHiA GENETICS (NASDAQ: SOPH) is a more mature AI healthcare company focused on data-driven medicine, especially genomics and precision oncology. Its SOPHiA DDM™ platform helps healthcare providers analyze multimodal medical data and apply AI-supported insights to clinical and research workflows.

SOPH’s Q1 2026 results showed US$21.7M in revenue, up 22% year over year. The company also reported a record 108,000 genomic analyses on the platform and 537 core genomics customers, up from 490 a year earlier.

• Investor data point: SOPH guided for full-year 2026 revenue of US$92M–US$94M, implying roughly 20%–22% growth.

SOPH is useful as a comparison for AIMLF because it shows what healthcare AI can look like when a platform gains measurable adoption across labs and hospitals. The risk is that SOPH still needs to show a clearer path toward profitability and cash-flow discipline.

https://preview.redd.it/h80o90enth2h1.png?width=1196&format=png&auto=webp&s=640ea61889412ad2741b768a270eb441854d4fc1

3. Recursion Pharmaceuticals: AI Drug Discovery With Cash Runway

Recursion Pharmaceuticals (NASDAQ: RXRX) is one of the most recognized AI drug-discovery companies. Its platform uses automation, machine learning, biological datasets, and computational tools to identify and advance drug candidates.

Recursion’s Q1 2026 update showed US$6.5M in revenue, mostly from collaboration agreements, and US$665.2M in cash, cash equivalents, and restricted cash as of March 31, 2026. The company also said its cash runway extends into early 2028 under current operating plans.

• Investor data point: RXRX’s Q1 cash operating expense was US$85.1M, showing both the scale of its platform ambitions and the capital intensity of AI drug discovery.

For investors, RXRX offers exposure to the idea that AI can improve the speed and efficiency of drug discovery. The risk is that drug development remains expensive, uncertain, and milestone-driven, even when powered by AI.

https://preview.redd.it/iyh86a1pth2h1.png?width=1196&format=png&auto=webp&s=b460c2b9c8394fd3ba25c0167ce790f8a3e1794c

4. Schrödinger: Computational Drug Discovery and Software

Schrödinger (NASDAQ: SDGR) gives investors exposure to computational drug discovery, molecular modeling, and scientific software. The company combines a software platform used by life-sciences customers with a drug-discovery pipeline.

Its Q1 2026 update highlighted US$28M in first-quarter annual contract value, representing 12% growth. Schrödinger also said it plans to launch Bunsen, an agentic AI co-scientist, this summer, showing how AI is becoming more embedded in computational research workflows.

• Investor data point: SDGR’s model gives investors two revenue angles: software adoption today and longer-term upside from internally developed or partnered drug candidates.

SDGR is a reminder that AI healthcare does not always mean direct patient-facing tools. Some of the opportunity sits inside the research and discovery stack. The risk is that drug-discovery upside can take years to convert into meaningful earnings.

https://preview.redd.it/dqq57lpqth2h1.png?width=1196&format=png&auto=webp&s=caca701eaba911b3dc1c59f3f3473b091497116c

5. Butterfly Network: AI-Enabled Medical Imaging

Butterfly Network (NYSE: BFLY) gives investors exposure to AI-enabled imaging and portable ultrasound. The company’s handheld ultrasound platform is designed to make imaging more accessible, portable, and software-driven.

Butterfly reported Q1 2026 revenue of US$26.5M, up 25% year over year. Gross profit was US$18.3M, and gross margin improved to 68.9%, compared with 63.0% in the prior-year period.

• Investor data point: BFLY reaffirmed full-year 2026 revenue guidance of US$117M–US$121M, giving it one of the clearer revenue bases in this AI healthcare basket.

Butterfly is useful as a comparison because it shows how AI can move into devices and diagnostics, not just software dashboards or drug-discovery platforms. The risk is that device adoption, hospital budgets, and profitability still need to improve over time.

https://preview.redd.it/qnqgri7sth2h1.png?width=1196&format=png&auto=webp&s=6d8449188e480116cd9b6ac6f67860f6fa9e82c5

Stock Snapshot

https://preview.redd.it/7d1cvultth2h1.png?width=1196&format=png&auto=webp&s=927891e906c0267c7e0c8b3578156a40a0160e63

Bottom Line

AI/ML Innovations is the speculative micro-cap in this AI healthcare basket. AIMLF has a focused ECG-AI angle, fresh clinical credibility through Dr. Martin Green, and exposure to cardiovascular-data workflows where automation could matter.

The larger names show how broad the AI healthcare theme has become: SOPH in genomics, RXRX and SDGR in drug discovery, and BFLY in medical imaging. For AIMLF, the next proof points are validation, partnerships, pilots, recurring revenue, and whether NeuralCloud’s MaxYield™ platform can move from research credibility toward commercial adoption.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Sector catalyst: healthcare AI is moving into real clinical workflows, from ECG processing and genomics to drug discovery and portable imaging.
• Investor angle: AIML is the micro-cap ECG-AI name in this basket, while SOPH, RXRX, SDGR, and BFLY show how larger AI healthcare platforms are already building commercial scale.

AI healthcare is becoming one of the more investable areas of the artificial intelligence market because the use cases are moving closer to real clinical workflows. Hospitals, research institutes, diagnostic labs, pharma companies, and device makers are all looking for ways to process medical data faster and more accurately.

For investors, the opportunity is not just “AI in medicine.” The real question is which companies have useful data, credible clinical partners, commercial adoption, enough cash to execute, and a product that solves a measurable healthcare bottleneck. That is why this watchlist combines one speculative micro-cap, AI/ML Innovations (AIMLF), with four larger AI healthcare names: SOPHiA GENETICS, Recursion Pharmaceuticals, Schrödinger, and Butterfly Network.

Market Catalyst: AI Is Moving Into Healthcare Workflows

Healthcare AI is already appearing in ECG interpretation, Holter analysis, precision oncology, genomics, ultrasound imaging, drug discovery, clinical trial design, and hospital decision support. The sector is attractive because healthcare creates enormous volumes of data, but much of that data remains fragmented, difficult to structure, and time-consuming for clinicians to review.

The numbers explain why investors are watching the space. Grand View Research estimated the global AI healthcare market at roughly US$26.6B in 2024, with a high-growth outlook through the end of the decade. Cardiovascular disease remains one of the world’s largest healthcare burdens, responsible for roughly 17.9M deaths per year, while Holter monitoring can generate 24 hours to 14 days of continuous rhythm data per patient.

Two data points show why this matters:

• Clinical data volumes are expanding quickly: ECG, Holter, genomic, imaging, and monitoring workflows generate large datasets where automation, labeling, pattern recognition, and signal processing can reduce bottlenecks.
• Commercial adoption is already visible: SOPHiA GENETICS processed 108,000 genomic analyses in Q1 2026, while Butterfly Network generated US$26.5M of Q1 2026 revenue, up 25% year over year.

The opportunity is real, but healthcare AI is not an easy market. Companies still need clinical validation, regulatory discipline, reimbursement pathways, hospital procurement access, commercial traction, cash runway, and proof that their platforms can scale beyond pilots.

1. AI/ML Innovations: The Micro-Cap ECG-AI Angle

AI/ML Innovations Inc. (CSE: AIML / OTCQB: AIMLF) is the smallest and most speculative name in this AI healthcare basket. The company is focused on digital health and artificial intelligence, with its NeuralCloud subsidiary targeting ECG signal processing, Holter analysis, and cardiovascular-data workflows.

The core platform is MaxYield™, NeuralCloud’s ECG signal-processing technology. AIML says MaxYield™ is designed to convert raw or legacy ECG data into structured, machine-readable formats, isolate and label ECG waveform components, and generate beat-level data and interval measurements.

• Investor data point: AIMLF trades around US$0.037–US$0.040, with market cap around US$7M–US$10M and roughly 271.1M shares outstanding.

The latest credibility catalyst is AIML’s appointment of Dr. Martin Stephen Green to its Medical Advisory Board. Dr. Green brings about 45 years of ECG and Holter interpretation experience and has authored or co-authored more than 230 peer-reviewed publications. For AIMLF, this matters because ECG-AI adoption requires physician trust, not just software capability.

https://preview.redd.it/d1kie0fpsh2h1.png?width=1196&format=png&auto=webp&s=b8d8ad0fa560c1254d379a7724f5f887d0a4d111

2. SOPHiA GENETICS: AI Precision Medicine at Commercial Scale

SOPHiA GENETICS (NASDAQ: SOPH) is a more mature AI healthcare company focused on data-driven medicine, especially genomics and precision oncology. Its SOPHiA DDM™ platform helps healthcare providers analyze multimodal medical data and apply AI-supported insights to clinical and research workflows.

SOPH’s Q1 2026 results showed US$21.7M in revenue, up 22% year over year. The company also reported a record 108,000 genomic analyses on the platform and 537 core genomics customers, up from 490 a year earlier.

• Investor data point: SOPH guided for full-year 2026 revenue of US$92M–US$94M, implying roughly 20%–22% growth.

SOPH is useful as a comparison for AIMLF because it shows what healthcare AI can look like when a platform gains measurable adoption across labs and hospitals. The risk is that SOPH still needs to show a clearer path toward profitability and cash-flow discipline.

https://preview.redd.it/hojfrxersh2h1.png?width=1196&format=png&auto=webp&s=cade7c9eab9fedd981fdbc19386bafbe66593d15

3. Recursion Pharmaceuticals: AI Drug Discovery With Cash Runway

Recursion Pharmaceuticals (NASDAQ: RXRX) is one of the most recognized AI drug-discovery companies. Its platform uses automation, machine learning, biological datasets, and computational tools to identify and advance drug candidates.

Recursion’s Q1 2026 update showed US$6.5M in revenue, mostly from collaboration agreements, and US$665.2M in cash, cash equivalents, and restricted cash as of March 31, 2026. The company also said its cash runway extends into early 2028 under current operating plans.

• Investor data point: RXRX’s Q1 cash operating expense was US$85.1M, showing both the scale of its platform ambitions and the capital intensity of AI drug discovery.

For investors, RXRX offers exposure to the idea that AI can improve the speed and efficiency of drug discovery. The risk is that drug development remains expensive, uncertain, and milestone-driven, even when powered by AI.

https://preview.redd.it/5hbdbjkush2h1.png?width=1196&format=png&auto=webp&s=9b64b77b3cbe10bcdae1507e045052f24a976baa

4. Schrödinger: Computational Drug Discovery and Software

Schrödinger (NASDAQ: SDGR) gives investors exposure to computational drug discovery, molecular modeling, and scientific software. The company combines a software platform used by life-sciences customers with a drug-discovery pipeline.

Its Q1 2026 update highlighted US$28M in first-quarter annual contract value, representing 12% growth. Schrödinger also said it plans to launch Bunsen, an agentic AI co-scientist, this summer, showing how AI is becoming more embedded in computational research workflows.

• Investor data point: SDGR’s model gives investors two revenue angles: software adoption today and longer-term upside from internally developed or partnered drug candidates.

SDGR is a reminder that AI healthcare does not always mean direct patient-facing tools. Some of the opportunity sits inside the research and discovery stack. The risk is that drug-discovery upside can take years to convert into meaningful earnings.

https://preview.redd.it/6jrniooath2h1.png?width=1196&format=png&auto=webp&s=b01503ee287dd186cadd4134ce7ab7b69f62853a

5. Butterfly Network: AI-Enabled Medical Imaging

Butterfly Network (NYSE: BFLY) gives investors exposure to AI-enabled imaging and portable ultrasound. The company’s handheld ultrasound platform is designed to make imaging more accessible, portable, and software-driven.

Butterfly reported Q1 2026 revenue of US$26.5M, up 25% year over year. Gross profit was US$18.3M, and gross margin improved to 68.9%, compared with 63.0% in the prior-year period.

• Investor data point: BFLY reaffirmed full-year 2026 revenue guidance of US$117M–US$121M, giving it one of the clearer revenue bases in this AI healthcare basket.

Butterfly is useful as a comparison because it shows how AI can move into devices and diagnostics, not just software dashboards or drug-discovery platforms. The risk is that device adoption, hospital budgets, and profitability still need to improve over time.

https://preview.redd.it/0b1p219cth2h1.png?width=1196&format=png&auto=webp&s=81200e591a6154509c99b2253ad2924ba15a9694

Stock Snapshot

https://preview.redd.it/j1s6d5odth2h1.png?width=1196&format=png&auto=webp&s=7723f7549251bccd23f6feabc92a6de47644c592

Bottom Line

AI/ML Innovations is the speculative micro-cap in this AI healthcare basket. AIMLF has a focused ECG-AI angle, fresh clinical credibility through Dr. Martin Green, and exposure to cardiovascular-data workflows where automation could matter.

The larger names show how broad the AI healthcare theme has become: SOPH in genomics, RXRX and SDGR in drug discovery, and BFLY in medical imaging. For AIMLF, the next proof points are validation, partnerships, pilots, recurring revenue, and whether NeuralCloud’s MaxYield™ platform can move from research credibility toward commercial adoption.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Sector catalyst: healthcare AI is moving into real clinical workflows, from ECG processing and genomics to drug discovery and portable imaging.
• Investor angle: AIML is the micro-cap ECG-AI name in this basket, while SOPH, RXRX, SDGR, and BFLY show how larger AI healthcare platforms are already building commercial scale.

AI healthcare is becoming one of the more investable areas of the artificial intelligence market because the use cases are moving closer to real clinical workflows. Hospitals, research institutes, diagnostic labs, pharma companies, and device makers are all looking for ways to process medical data faster and more accurately.

For investors, the opportunity is not just “AI in medicine.” The real question is which companies have useful data, credible clinical partners, commercial adoption, enough cash to execute, and a product that solves a measurable healthcare bottleneck. That is why this watchlist combines one speculative micro-cap, AI/ML Innovations (AIMLF), with four larger AI healthcare names: SOPHiA GENETICS, Recursion Pharmaceuticals, Schrödinger, and Butterfly Network.

Market Catalyst: AI Is Moving Into Healthcare Workflows

Healthcare AI is already appearing in ECG interpretation, Holter analysis, precision oncology, genomics, ultrasound imaging, drug discovery, clinical trial design, and hospital decision support. The sector is attractive because healthcare creates enormous volumes of data, but much of that data remains fragmented, difficult to structure, and time-consuming for clinicians to review.

The numbers explain why investors are watching the space. Grand View Research estimated the global AI healthcare market at roughly US$26.6B in 2024, with a high-growth outlook through the end of the decade. Cardiovascular disease remains one of the world’s largest healthcare burdens, responsible for roughly 17.9M deaths per year, while Holter monitoring can generate 24 hours to 14 days of continuous rhythm data per patient.

Two data points show why this matters:

• Clinical data volumes are expanding quickly: ECG, Holter, genomic, imaging, and monitoring workflows generate large datasets where automation, labeling, pattern recognition, and signal processing can reduce bottlenecks.
• Commercial adoption is already visible: SOPHiA GENETICS processed 108,000 genomic analyses in Q1 2026, while Butterfly Network generated US$26.5M of Q1 2026 revenue, up 25% year over year.

The opportunity is real, but healthcare AI is not an easy market. Companies still need clinical validation, regulatory discipline, reimbursement pathways, hospital procurement access, commercial traction, cash runway, and proof that their platforms can scale beyond pilots.

1. AI/ML Innovations: The Micro-Cap ECG-AI Angle

AI/ML Innovations Inc. (CSE: AIML / OTCQB: AIMLF) is the smallest and most speculative name in this AI healthcare basket. The company is focused on digital health and artificial intelligence, with its NeuralCloud subsidiary targeting ECG signal processing, Holter analysis, and cardiovascular-data workflows.

The core platform is MaxYield™, NeuralCloud’s ECG signal-processing technology. AIML says MaxYield™ is designed to convert raw or legacy ECG data into structured, machine-readable formats, isolate and label ECG waveform components, and generate beat-level data and interval measurements.

• Investor data point: AIMLF trades around US$0.037–US$0.040, with market cap around US$7M–US$10M and roughly 271.1M shares outstanding.

The latest credibility catalyst is AIML’s appointment of Dr. Martin Stephen Green to its Medical Advisory Board. Dr. Green brings about 45 years of ECG and Holter interpretation experience and has authored or co-authored more than 230 peer-reviewed publications. For AIMLF, this matters because ECG-AI adoption requires physician trust, not just software capability.

https://preview.redd.it/hligwcpvqh2h1.png?width=1196&format=png&auto=webp&s=2389e38dcbc71ccadadc1244988fab9320253cb1

2. SOPHiA GENETICS: AI Precision Medicine at Commercial Scale

SOPHiA GENETICS (NASDAQ: SOPH) is a more mature AI healthcare company focused on data-driven medicine, especially genomics and precision oncology. Its SOPHiA DDM™ platform helps healthcare providers analyze multimodal medical data and apply AI-supported insights to clinical and research workflows.

SOPH’s Q1 2026 results showed US$21.7M in revenue, up 22% year over year. The company also reported a record 108,000 genomic analyses on the platform and 537 core genomics customers, up from 490 a year earlier.

• Investor data point: SOPH guided for full-year 2026 revenue of US$92M–US$94M, implying roughly 20%–22% growth.

SOPH is useful as a comparison for AIMLF because it shows what healthcare AI can look like when a platform gains measurable adoption across labs and hospitals. The risk is that SOPH still needs to show a clearer path toward profitability and cash-flow discipline.

https://preview.redd.it/f895c7j0rh2h1.png?width=1196&format=png&auto=webp&s=d2e28a55e16f900d3ae2ec5e59d753b0cecedac4

3. Recursion Pharmaceuticals: AI Drug Discovery With Cash Runway

Recursion Pharmaceuticals (NASDAQ: RXRX) is one of the most recognized AI drug-discovery companies. Its platform uses automation, machine learning, biological datasets, and computational tools to identify and advance drug candidates.

Recursion’s Q1 2026 update showed US$6.5M in revenue, mostly from collaboration agreements, and US$665.2M in cash, cash equivalents, and restricted cash as of March 31, 2026. The company also said its cash runway extends into early 2028 under current operating plans.

• Investor data point: RXRX’s Q1 cash operating expense was US$85.1M, showing both the scale of its platform ambitions and the capital intensity of AI drug discovery.

For investors, RXRX offers exposure to the idea that AI can improve the speed and efficiency of drug discovery. The risk is that drug development remains expensive, uncertain, and milestone-driven, even when powered by AI.

https://preview.redd.it/yzo1iil3rh2h1.png?width=1196&format=png&auto=webp&s=1ffc31c3cb7733bd81bd464bd60e918508dea17d

4. Schrödinger: Computational Drug Discovery and Software

Schrödinger (NASDAQ: SDGR) gives investors exposure to computational drug discovery, molecular modeling, and scientific software. The company combines a software platform used by life-sciences customers with a drug-discovery pipeline.

Its Q1 2026 update highlighted US$28M in first-quarter annual contract value, representing 12% growth. Schrödinger also said it plans to launch Bunsen, an agentic AI co-scientist, this summer, showing how AI is becoming more embedded in computational research workflows.

• Investor data point: SDGR’s model gives investors two revenue angles: software adoption today and longer-term upside from internally developed or partnered drug candidates.

SDGR is a reminder that AI healthcare does not always mean direct patient-facing tools. Some of the opportunity sits inside the research and discovery stack. The risk is that drug-discovery upside can take years to convert into meaningful earnings.

https://preview.redd.it/jzy8oa85sh2h1.png?width=1196&format=png&auto=webp&s=6e0781054392f0884633fc943cf52f683578f125

5. Butterfly Network: AI-Enabled Medical Imaging

Butterfly Network (NYSE: BFLY) gives investors exposure to AI-enabled imaging and portable ultrasound. The company’s handheld ultrasound platform is designed to make imaging more accessible, portable, and software-driven.

Butterfly reported Q1 2026 revenue of US$26.5M, up 25% year over year. Gross profit was US$18.3M, and gross margin improved to 68.9%, compared with 63.0% in the prior-year period.

• Investor data point: BFLY reaffirmed full-year 2026 revenue guidance of US$117M–US$121M, giving it one of the clearer revenue bases in this AI healthcare basket.

Butterfly is useful as a comparison because it shows how AI can move into devices and diagnostics, not just software dashboards or drug-discovery platforms. The risk is that device adoption, hospital budgets, and profitability still need to improve over time.

https://preview.redd.it/1w00jnx7sh2h1.png?width=1196&format=png&auto=webp&s=3ae2c5abd59c6784a7b0717d3581ba30122c007c

Stock Snapshot

https://preview.redd.it/y2x8bvubsh2h1.png?width=1196&format=png&auto=webp&s=3024904d811cc6a32bec17adcd7fcfb1b29daabf

Bottom Line

AI/ML Innovations is the speculative micro-cap in this AI healthcare basket. AIMLF has a focused ECG-AI angle, fresh clinical credibility through Dr. Martin Green, and exposure to cardiovascular-data workflows where automation could matter.

The larger names show how broad the AI healthcare theme has become: SOPH in genomics, RXRX and SDGR in drug discovery, and BFLY in medical imaging. For AIMLF, the next proof points are validation, partnerships, pilots, recurring revenue, and whether NeuralCloud’s MaxYield™ platform can move from research credibility toward commercial adoption.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

VANCOUVER, British Columbia, May 19, 2026 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that it has commenced a 32.4 km^(2) induced polarization (“IP”) geophysical survey on its 100% owned Stars Property (“Stars” or the “Property”). Stars is a porphyry copper-molybdenum (“Cu-Mo”) project covering 9,693 hectares (“ha”) in the Stikine region of British Columbia, situated approximately 60 km north of Imperial Metals Corporation’s (“Imperial Metals”) past producing Huckleberry Cu-Mo mine, 50 km north-northeast of Surge Copper Corp’s advanced stage Berg copper project, and 30 km north-northwest of Vizsla Copper Corp’s Poplar copper-gold project. Imperial Metals is exploring Huckleberry and its surrounding claims for additional Cu-Mo resources.

This very large IP survey represents the first time this geophysical technique has been applied across the full extent of the Stars Property, including over the Tana Zone discovery area and its along-strike extensions. Induced polarization is a proven method for detecting sulphide mineralization, the type of copper-bearing material found at Stars, at depth and at distance from known drill holes. By imaging the full 32.4 km² footprint of the magnetic anomaly, the Company aims to determine the true scale of the mineralized system in terms of strike length, width, and depth, and to identify potential new drill targets beyond the current Tana Zone.

Highlights of the Stars Property:

• Road accessible, 9,693 ha property in a top tier exploration and mining district, the Bulkley Porphyry Belt.
• A 230 X 180 metre (“m”) domain (the “Tana Zone”) of chalcopyrite-molybdenite-bornite quartz stockwork that has been intersected from surface to greater than 350 m depth. The zone is open in two directions as well as to depth. Drill Intersection highlights include:
  • 0.466% Cu over 195.07 m* in drill hole DD18SS004 from 23.47 m
  • 0.200% Cu over 396.67 m* in drill hole DD18SS010 from 29.37 m
  • 0.205% Cu over 207.27 m* in drill hole DD18SS015 from 163.98 m
• A highly prospective, approximately 5 X 2.5 kilometre (“km”), annular magnetic anomaly that is interpreted as an altered monzonite intrusion and surrounding hornfels (Figure 1).
• Numerous underexplored soil and induced polarization geophysical targets within the larger magnetic anomaly (Figure 1).

Brian Thurston, President & CEO of Copper Quest, commented: "Copper Quest controls 9,693 ha covering the Stars Property and prospective surrounding area with two complementary exploration upsides being an established zone of higher-grade mineralization that the Company can grow and define, and a much broader under-explored area with high potential for new discovery. This is a very large geophysical program that combined with the historic 9,016 m of drilling will help guide exploration to provide the best information to make new discoveries in this very large anomaly that has a footprint five times that of the Huckleberry Mine. Combined with the contiguous 5,389 ha Stellar Property, Copper Quest has assembled a dominant land position and created a unique opportunity that unlocks a district scale copper porphyry project in the Bulkley Porphyry Belt. Given the global movement towards AI, electrification, environmental concerns, infrastructure development, and the forecasted demand for copper, the combined properties make a very compelling exploration package."

The Stars Property

The 9,693 ha, road-accessible Stars Property is located in central British Columbia, 40 km southwest of Houston. It hosts porphyry copper-molybdenum mineralization associated with a Bulkley Suite monzonite stock. The Bulkley Suite is linked to mineralization at Imperial Metals' past-producing Huckleberry mine, 60 km to the south, and other porphyry deposits in the region. Three drilling campaigns on the Stars Property, totaling 9,016 m, have identified a broad area of anomalous copper, and molybdenum within the monzonite stock. The most important drilling to date is at the Tana Zone (Figure 1), where the contact between the stock and surrounding volcanic rock contains chalcopyrite, molybdenite and bornite bearing quartz stockwork veining. Tana Zone drilling has defined an approximately 230 x 180 m domain with significant copper and molybdenum grades (Table 1).

Table 1: Highlights of Tana Zone Intersections*

https://preview.redd.it/m242bjzioh2h1.png?width=1508&format=png&auto=webp&s=ac78dbeb7199a9683aef956933c878c3167a7f80

Outside the Tana Zone, most drilling on the property encountered altered and anomalous mineralized monzonite within an approximately 1.8 x 1.0 km area marked by a broad magnetic low (Fig. 1). While there is potential for an undiscovered porphyry deposit within the monzonite intrusion, Copper Quest's future exploration will concentrate on specific IP targets along the contact zones. Several historical drill holes are believed to have approached this contact, with assays at their bottoms showing increased copper and molybdenite values (Table 2). Their drill logs also indicate an increase in quartz-chalcopyrite-molybdenite ± bornite veins with pink K-feldspar altered selvages, similar to those found in the Tana Zone.

Table 2: Drill intersections indicating grassroots exploration opportunities*

https://preview.redd.it/vzqhr1dkoh2h1.png?width=1508&format=png&auto=webp&s=8e0367616b3e119f5988f539daf02aac03b39b48

* True width of historical drill intersections referenced in this press release are unknown. Historical drill data in this release is derived from previous exploration activities conducted by other parties. While this data may provide insights into the mineralization potential on the property, it should not be relied upon as conclusive evidence of mineral potential or project viability.

https://preview.redd.it/54ih5f2moh2h1.png?width=1144&format=png&auto=webp&s=d15715b32766e744b4c2999a5fb740ea2adcddb9

Map of Exploration Targets on the Stars Property. Datum NAD83 UTM Zone 9. Historical drilling and exploration vectors on total-magnetic-intensity geophysical map

Figure 1: Map of Exploration Targets on the Stars Property. Datum NAD83 UTM Zone 9. Historical drilling and exploration vectors on total-magnetic-intensity geophysical map.

Qualified Person

Brian Thurston, P.Geo., the Company’s President, CEO and a qualified person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information in this news release.

About Copper

Copper is an essential industrial metal at the heart of the global energy transition and modern infrastructure. It plays a critical role in electrification, renewable energy systems, electric vehicles, data centers, and smart technologies. With global demand rising and new supply challenged by declining grades, complex permitting, and underinvestment, the copper market faces persistent deficits and growing geopolitical scrutiny. Recent U.S. policy announcements, including import tariffs and initiatives to secure domestic and allied supply chains, underscore copper’s strategic importance and the need for resilient, localized resource exploration, development, production and processing capacity.

About Copper Quest Exploration Inc.

The Company's land holdings comprise 8 projects that span over 46,000 hectares in great mining jurisdictions of Canada and the USA. Copper Quest is committed to building shareholder value through acquisitions, discovery-driven exploration, and responsible development of its North American portfolio of assets. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”. For more information on Copper Quest, please visit the Company’s website at www.copper.quest.

Copper Quest has a 100% interest in the past-producing Alpine Gold Mine located approximately 20 kilometers northeast of the City of Nelson British Columbia, spanning 4,611.49 hectares with a 2018 National Instrument 43-101 Standards of Disclosure for Mineral Projects historical inferred resource of 268,000 tonnes, estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au, that represents an inferred resource of 142,000 oz of gold* (*McCuaig & Giroux, March 6, 2018, NI43-101 Technical Report for the Alpine Property, BC, Canada. Further drilling is necessary by the Company to upgrade/verify the estimate. The QP has not done sufficient work to make the resource current and the Company is not treating the estimate as current.). Apart from the Alpine Mine itself the property hosts 4 other less explored significant vein systems including the past-producing King Solomon vein workings, the Black Prince and the Cold Blow veins system, and the Gold Crown vein system. *The Company has not yet completed sufficient work to verify the 2018 historic inferred resource results.

Copper Quest has a 100% interest in the road accessible Stars Porphyry Copper-Molybdenum Property, spanning 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt with Tana Zone discovery drill intersection highlights of 0.466% Cu over 195.07m in drill hole DD18SS004 from 23.47m, 0.200% Cu over 396.67m in drill hole DD18SS010 from 29.37m, and 0.205% Cu over 207.27m in drill hole DD18SS015 from 163.98m. This highly prospective, approximately 5X2.5-kilometer annular magnetic anomaly is interpreted to represent an altered monzonite intrusion and surrounding hornfels.

Copper Quest has a 100% interest in the road accessible Kitimat Copper-Gold Property, spanning 2,954 hectares within the Skeena Mining Division of northwestern British Columbia located northwest of the deep-water port community of Kitimat, British Columbia. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines. Exploration on the Kitimat property dates to the late 1960s, with the most significant historical work conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone, and drill intersection highlights of 0.54% Cu and 1.03 g/t Au over 117.07 m in Hole J-7 from 1.52 m, 0.55% Cu and 1.00 g/t Au over 103.65m in Hole J-1 from 9.15 m, 0.45% Cu and 0.80 g/t Au over 107.01m in Hole J-2 from 6.10 m, and 0.33% Cu and 0.41 g/t Au over 112.20m in Hole J-8 from 11.89 m.

Copper Quest has a 100% interest in the past-producing, road accessible Auxer Gold Mine, spanning 1,087 hectares located in Bonner County, Idaho, USA. This orogenic gold opportunity is positioned along one of the region’s most significant structural corridors located within the prolific Hope Fault system. Historical exploration has demonstrated exceptional gold grades, with the 1936 Platts report documenting up to 21.0 g/t Au in surface samples and underground workings showing consistent mineralization over 4.3-meter widths averaging 9.42 g/t Au at an 18-meter depth.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, USA, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the road accessible Stellar Property, spanning 5,389-hectares in British Columbia’s Bulkley Porphyry Belt contiguous to the Stars Property.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern British Columbia spanning over 20,658 hectares with 10 priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest has an earn-in option of up to 80% and joint-venture agreement on the road accessible Rip Porphyry Copper-Molybdenum Project, spanning 4,700-hectares located in the Bulkley Porphyry Belt in central British Columbia.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

VANCOUVER, British Columbia, May 19, 2026 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that it has commenced a 32.4 km^(2) induced polarization (“IP”) geophysical survey on its 100% owned Stars Property (“Stars” or the “Property”). Stars is a porphyry copper-molybdenum (“Cu-Mo”) project covering 9,693 hectares (“ha”) in the Stikine region of British Columbia, situated approximately 60 km north of Imperial Metals Corporation’s (“Imperial Metals”) past producing Huckleberry Cu-Mo mine, 50 km north-northeast of Surge Copper Corp’s advanced stage Berg copper project, and 30 km north-northwest of Vizsla Copper Corp’s Poplar copper-gold project. Imperial Metals is exploring Huckleberry and its surrounding claims for additional Cu-Mo resources.

This very large IP survey represents the first time this geophysical technique has been applied across the full extent of the Stars Property, including over the Tana Zone discovery area and its along-strike extensions. Induced polarization is a proven method for detecting sulphide mineralization, the type of copper-bearing material found at Stars, at depth and at distance from known drill holes. By imaging the full 32.4 km² footprint of the magnetic anomaly, the Company aims to determine the true scale of the mineralized system in terms of strike length, width, and depth, and to identify potential new drill targets beyond the current Tana Zone.

Highlights of the Stars Property:

• Road accessible, 9,693 ha property in a top tier exploration and mining district, the Bulkley Porphyry Belt.
• A 230 X 180 metre (“m”) domain (the “Tana Zone”) of chalcopyrite-molybdenite-bornite quartz stockwork that has been intersected from surface to greater than 350 m depth. The zone is open in two directions as well as to depth. Drill Intersection highlights include:
  • 0.466% Cu over 195.07 m* in drill hole DD18SS004 from 23.47 m
  • 0.200% Cu over 396.67 m* in drill hole DD18SS010 from 29.37 m
  • 0.205% Cu over 207.27 m* in drill hole DD18SS015 from 163.98 m
• A highly prospective, approximately 5 X 2.5 kilometre (“km”), annular magnetic anomaly that is interpreted as an altered monzonite intrusion and surrounding hornfels (Figure 1).
• Numerous underexplored soil and induced polarization geophysical targets within the larger magnetic anomaly (Figure 1).

Brian Thurston, President & CEO of Copper Quest, commented: "Copper Quest controls 9,693 ha covering the Stars Property and prospective surrounding area with two complementary exploration upsides being an established zone of higher-grade mineralization that the Company can grow and define, and a much broader under-explored area with high potential for new discovery. This is a very large geophysical program that combined with the historic 9,016 m of drilling will help guide exploration to provide the best information to make new discoveries in this very large anomaly that has a footprint five times that of the Huckleberry Mine. Combined with the contiguous 5,389 ha Stellar Property, Copper Quest has assembled a dominant land position and created a unique opportunity that unlocks a district scale copper porphyry project in the Bulkley Porphyry Belt. Given the global movement towards AI, electrification, environmental concerns, infrastructure development, and the forecasted demand for copper, the combined properties make a very compelling exploration package."

The Stars Property

The 9,693 ha, road-accessible Stars Property is located in central British Columbia, 40 km southwest of Houston. It hosts porphyry copper-molybdenum mineralization associated with a Bulkley Suite monzonite stock. The Bulkley Suite is linked to mineralization at Imperial Metals' past-producing Huckleberry mine, 60 km to the south, and other porphyry deposits in the region. Three drilling campaigns on the Stars Property, totaling 9,016 m, have identified a broad area of anomalous copper, and molybdenum within the monzonite stock. The most important drilling to date is at the Tana Zone (Figure 1), where the contact between the stock and surrounding volcanic rock contains chalcopyrite, molybdenite and bornite bearing quartz stockwork veining. Tana Zone drilling has defined an approximately 230 x 180 m domain with significant copper and molybdenum grades (Table 1).

Table 1: Highlights of Tana Zone Intersections*

https://preview.redd.it/3nkkvxvenh2h1.png?width=1508&format=png&auto=webp&s=2ce16314d32b844ee511a3ed35049e7265907fc8

Outside the Tana Zone, most drilling on the property encountered altered and anomalous mineralized monzonite within an approximately 1.8 x 1.0 km area marked by a broad magnetic low (Fig. 1). While there is potential for an undiscovered porphyry deposit within the monzonite intrusion, Copper Quest's future exploration will concentrate on specific IP targets along the contact zones. Several historical drill holes are believed to have approached this contact, with assays at their bottoms showing increased copper and molybdenite values (Table 2). Their drill logs also indicate an increase in quartz-chalcopyrite-molybdenite ± bornite veins with pink K-feldspar altered selvages, similar to those found in the Tana Zone.

Table 2: Drill intersections indicating grassroots exploration opportunities*

https://preview.redd.it/tc973zxgnh2h1.png?width=1508&format=png&auto=webp&s=f3522c044d5b71527283557e035ff3af3e27a970

* True width of historical drill intersections referenced in this press release are unknown. Historical drill data in this release is derived from previous exploration activities conducted by other parties. While this data may provide insights into the mineralization potential on the property, it should not be relied upon as conclusive evidence of mineral potential or project viability.

https://preview.redd.it/vuaz9xejnh2h1.png?width=1144&format=png&auto=webp&s=65903e3cd66b12d694dc0edf9a4a86786218780b

Map of Exploration Targets on the Stars Property. Datum NAD83 UTM Zone 9. Historical drilling and exploration vectors on total-magnetic-intensity geophysical map

Figure 1: Map of Exploration Targets on the Stars Property. Datum NAD83 UTM Zone 9. Historical drilling and exploration vectors on total-magnetic-intensity geophysical map.

Qualified Person

Brian Thurston, P.Geo., the Company’s President, CEO and a qualified person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information in this news release.

About Copper

Copper is an essential industrial metal at the heart of the global energy transition and modern infrastructure. It plays a critical role in electrification, renewable energy systems, electric vehicles, data centers, and smart technologies. With global demand rising and new supply challenged by declining grades, complex permitting, and underinvestment, the copper market faces persistent deficits and growing geopolitical scrutiny. Recent U.S. policy announcements, including import tariffs and initiatives to secure domestic and allied supply chains, underscore copper’s strategic importance and the need for resilient, localized resource exploration, development, production and processing capacity.

About Copper Quest Exploration Inc.

The Company's land holdings comprise 8 projects that span over 46,000 hectares in great mining jurisdictions of Canada and the USA. Copper Quest is committed to building shareholder value through acquisitions, discovery-driven exploration, and responsible development of its North American portfolio of assets. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”. For more information on Copper Quest, please visit the Company’s website at www.copper.quest.

Copper Quest has a 100% interest in the past-producing Alpine Gold Mine located approximately 20 kilometers northeast of the City of Nelson British Columbia, spanning 4,611.49 hectares with a 2018 National Instrument 43-101 Standards of Disclosure for Mineral Projects historical inferred resource of 268,000 tonnes, estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au, that represents an inferred resource of 142,000 oz of gold* (*McCuaig & Giroux, March 6, 2018, NI43-101 Technical Report for the Alpine Property, BC, Canada. Further drilling is necessary by the Company to upgrade/verify the estimate. The QP has not done sufficient work to make the resource current and the Company is not treating the estimate as current.). Apart from the Alpine Mine itself the property hosts 4 other less explored significant vein systems including the past-producing King Solomon vein workings, the Black Prince and the Cold Blow veins system, and the Gold Crown vein system. *The Company has not yet completed sufficient work to verify the 2018 historic inferred resource results.

Copper Quest has a 100% interest in the road accessible Stars Porphyry Copper-Molybdenum Property, spanning 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt with Tana Zone discovery drill intersection highlights of 0.466% Cu over 195.07m in drill hole DD18SS004 from 23.47m, 0.200% Cu over 396.67m in drill hole DD18SS010 from 29.37m, and 0.205% Cu over 207.27m in drill hole DD18SS015 from 163.98m. This highly prospective, approximately 5X2.5-kilometer annular magnetic anomaly is interpreted to represent an altered monzonite intrusion and surrounding hornfels.

Copper Quest has a 100% interest in the road accessible Kitimat Copper-Gold Property, spanning 2,954 hectares within the Skeena Mining Division of northwestern British Columbia located northwest of the deep-water port community of Kitimat, British Columbia. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines. Exploration on the Kitimat property dates to the late 1960s, with the most significant historical work conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone, and drill intersection highlights of 0.54% Cu and 1.03 g/t Au over 117.07 m in Hole J-7 from 1.52 m, 0.55% Cu and 1.00 g/t Au over 103.65m in Hole J-1 from 9.15 m, 0.45% Cu and 0.80 g/t Au over 107.01m in Hole J-2 from 6.10 m, and 0.33% Cu and 0.41 g/t Au over 112.20m in Hole J-8 from 11.89 m.

Copper Quest has a 100% interest in the past-producing, road accessible Auxer Gold Mine, spanning 1,087 hectares located in Bonner County, Idaho, USA. This orogenic gold opportunity is positioned along one of the region’s most significant structural corridors located within the prolific Hope Fault system. Historical exploration has demonstrated exceptional gold grades, with the 1936 Platts report documenting up to 21.0 g/t Au in surface samples and underground workings showing consistent mineralization over 4.3-meter widths averaging 9.42 g/t Au at an 18-meter depth.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, USA, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the road accessible Stellar Property, spanning 5,389-hectares in British Columbia’s Bulkley Porphyry Belt contiguous to the Stars Property.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern British Columbia spanning over 20,658 hectares with 10 priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest has an earn-in option of up to 80% and joint-venture agreement on the road accessible Rip Porphyry Copper-Molybdenum Project, spanning 4,700-hectares located in the Bulkley Porphyry Belt in central British Columbia.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

VANCOUVER, British Columbia, May 19, 2026 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that it has commenced a 32.4 km^(2) induced polarization (“IP”) geophysical survey on its 100% owned Stars Property (“Stars” or the “Property”). Stars is a porphyry copper-molybdenum (“Cu-Mo”) project covering 9,693 hectares (“ha”) in the Stikine region of British Columbia, situated approximately 60 km north of Imperial Metals Corporation’s (“Imperial Metals”) past producing Huckleberry Cu-Mo mine, 50 km north-northeast of Surge Copper Corp’s advanced stage Berg copper project, and 30 km north-northwest of Vizsla Copper Corp’s Poplar copper-gold project. Imperial Metals is exploring Huckleberry and its surrounding claims for additional Cu-Mo resources.

This very large IP survey represents the first time this geophysical technique has been applied across the full extent of the Stars Property, including over the Tana Zone discovery area and its along-strike extensions. Induced polarization is a proven method for detecting sulphide mineralization, the type of copper-bearing material found at Stars, at depth and at distance from known drill holes. By imaging the full 32.4 km² footprint of the magnetic anomaly, the Company aims to determine the true scale of the mineralized system in terms of strike length, width, and depth, and to identify potential new drill targets beyond the current Tana Zone.

Highlights of the Stars Property:

• Road accessible, 9,693 ha property in a top tier exploration and mining district, the Bulkley Porphyry Belt.
• A 230 X 180 metre (“m”) domain (the “Tana Zone”) of chalcopyrite-molybdenite-bornite quartz stockwork that has been intersected from surface to greater than 350 m depth. The zone is open in two directions as well as to depth. Drill Intersection highlights include:
  • 0.466% Cu over 195.07 m* in drill hole DD18SS004 from 23.47 m
  • 0.200% Cu over 396.67 m* in drill hole DD18SS010 from 29.37 m
  • 0.205% Cu over 207.27 m* in drill hole DD18SS015 from 163.98 m
• A highly prospective, approximately 5 X 2.5 kilometre (“km”), annular magnetic anomaly that is interpreted as an altered monzonite intrusion and surrounding hornfels (Figure 1).
• Numerous underexplored soil and induced polarization geophysical targets within the larger magnetic anomaly (Figure 1).

Brian Thurston, President & CEO of Copper Quest, commented: "Copper Quest controls 9,693 ha covering the Stars Property and prospective surrounding area with two complementary exploration upsides being an established zone of higher-grade mineralization that the Company can grow and define, and a much broader under-explored area with high potential for new discovery. This is a very large geophysical program that combined with the historic 9,016 m of drilling will help guide exploration to provide the best information to make new discoveries in this very large anomaly that has a footprint five times that of the Huckleberry Mine. Combined with the contiguous 5,389 ha Stellar Property, Copper Quest has assembled a dominant land position and created a unique opportunity that unlocks a district scale copper porphyry project in the Bulkley Porphyry Belt. Given the global movement towards AI, electrification, environmental concerns, infrastructure development, and the forecasted demand for copper, the combined properties make a very compelling exploration package."

The Stars Property

The 9,693 ha, road-accessible Stars Property is located in central British Columbia, 40 km southwest of Houston. It hosts porphyry copper-molybdenum mineralization associated with a Bulkley Suite monzonite stock. The Bulkley Suite is linked to mineralization at Imperial Metals' past-producing Huckleberry mine, 60 km to the south, and other porphyry deposits in the region. Three drilling campaigns on the Stars Property, totaling 9,016 m, have identified a broad area of anomalous copper, and molybdenum within the monzonite stock. The most important drilling to date is at the Tana Zone (Figure 1), where the contact between the stock and surrounding volcanic rock contains chalcopyrite, molybdenite and bornite bearing quartz stockwork veining. Tana Zone drilling has defined an approximately 230 x 180 m domain with significant copper and molybdenum grades (Table 1).

Table 1: Highlights of Tana Zone Intersections*

https://preview.redd.it/gfot3n9wmh2h1.png?width=1508&format=png&auto=webp&s=e28d6f654eab6611952b59a3000edd5c2e101b80

Outside the Tana Zone, most drilling on the property encountered altered and anomalous mineralized monzonite within an approximately 1.8 x 1.0 km area marked by a broad magnetic low (Fig. 1). While there is potential for an undiscovered porphyry deposit within the monzonite intrusion, Copper Quest's future exploration will concentrate on specific IP targets along the contact zones. Several historical drill holes are believed to have approached this contact, with assays at their bottoms showing increased copper and molybdenite values (Table 2). Their drill logs also indicate an increase in quartz-chalcopyrite-molybdenite ± bornite veins with pink K-feldspar altered selvages, similar to those found in the Tana Zone.

Table 2: Drill intersections indicating grassroots exploration opportunities*

https://preview.redd.it/v24z2cnxmh2h1.png?width=1508&format=png&auto=webp&s=e3cbd0ac440d1a9de14c2e34eeb94635e58ceb33

* True width of historical drill intersections referenced in this press release are unknown. Historical drill data in this release is derived from previous exploration activities conducted by other parties. While this data may provide insights into the mineralization potential on the property, it should not be relied upon as conclusive evidence of mineral potential or project viability.

https://preview.redd.it/76wn6yczmh2h1.png?width=1144&format=png&auto=webp&s=05ba492916d794d933255058c1eba3d8d1f7ae06

Map of Exploration Targets on the Stars Property. Datum NAD83 UTM Zone 9. Historical drilling and exploration vectors on total-magnetic-intensity geophysical map

Figure 1: Map of Exploration Targets on the Stars Property. Datum NAD83 UTM Zone 9. Historical drilling and exploration vectors on total-magnetic-intensity geophysical map.

Qualified Person

Brian Thurston, P.Geo., the Company’s President, CEO and a qualified person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information in this news release.

About Copper

Copper is an essential industrial metal at the heart of the global energy transition and modern infrastructure. It plays a critical role in electrification, renewable energy systems, electric vehicles, data centers, and smart technologies. With global demand rising and new supply challenged by declining grades, complex permitting, and underinvestment, the copper market faces persistent deficits and growing geopolitical scrutiny. Recent U.S. policy announcements, including import tariffs and initiatives to secure domestic and allied supply chains, underscore copper’s strategic importance and the need for resilient, localized resource exploration, development, production and processing capacity.

About Copper Quest Exploration Inc.

The Company's land holdings comprise 8 projects that span over 46,000 hectares in great mining jurisdictions of Canada and the USA. Copper Quest is committed to building shareholder value through acquisitions, discovery-driven exploration, and responsible development of its North American portfolio of assets. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”. For more information on Copper Quest, please visit the Company’s website at www.copper.quest.

Copper Quest has a 100% interest in the past-producing Alpine Gold Mine located approximately 20 kilometers northeast of the City of Nelson British Columbia, spanning 4,611.49 hectares with a 2018 National Instrument 43-101 Standards of Disclosure for Mineral Projects historical inferred resource of 268,000 tonnes, estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au, that represents an inferred resource of 142,000 oz of gold* (*McCuaig & Giroux, March 6, 2018, NI43-101 Technical Report for the Alpine Property, BC, Canada. Further drilling is necessary by the Company to upgrade/verify the estimate. The QP has not done sufficient work to make the resource current and the Company is not treating the estimate as current.). Apart from the Alpine Mine itself the property hosts 4 other less explored significant vein systems including the past-producing King Solomon vein workings, the Black Prince and the Cold Blow veins system, and the Gold Crown vein system. *The Company has not yet completed sufficient work to verify the 2018 historic inferred resource results.

Copper Quest has a 100% interest in the road accessible Stars Porphyry Copper-Molybdenum Property, spanning 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt with Tana Zone discovery drill intersection highlights of 0.466% Cu over 195.07m in drill hole DD18SS004 from 23.47m, 0.200% Cu over 396.67m in drill hole DD18SS010 from 29.37m, and 0.205% Cu over 207.27m in drill hole DD18SS015 from 163.98m. This highly prospective, approximately 5X2.5-kilometer annular magnetic anomaly is interpreted to represent an altered monzonite intrusion and surrounding hornfels.

Copper Quest has a 100% interest in the road accessible Kitimat Copper-Gold Property, spanning 2,954 hectares within the Skeena Mining Division of northwestern British Columbia located northwest of the deep-water port community of Kitimat, British Columbia. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines. Exploration on the Kitimat property dates to the late 1960s, with the most significant historical work conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone, and drill intersection highlights of 0.54% Cu and 1.03 g/t Au over 117.07 m in Hole J-7 from 1.52 m, 0.55% Cu and 1.00 g/t Au over 103.65m in Hole J-1 from 9.15 m, 0.45% Cu and 0.80 g/t Au over 107.01m in Hole J-2 from 6.10 m, and 0.33% Cu and 0.41 g/t Au over 112.20m in Hole J-8 from 11.89 m.

Copper Quest has a 100% interest in the past-producing, road accessible Auxer Gold Mine, spanning 1,087 hectares located in Bonner County, Idaho, USA. This orogenic gold opportunity is positioned along one of the region’s most significant structural corridors located within the prolific Hope Fault system. Historical exploration has demonstrated exceptional gold grades, with the 1936 Platts report documenting up to 21.0 g/t Au in surface samples and underground workings showing consistent mineralization over 4.3-meter widths averaging 9.42 g/t Au at an 18-meter depth.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, USA, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the road accessible Stellar Property, spanning 5,389-hectares in British Columbia’s Bulkley Porphyry Belt contiguous to the Stars Property.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern British Columbia spanning over 20,658 hectares with 10 priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest has an earn-in option of up to 80% and joint-venture agreement on the road accessible Rip Porphyry Copper-Molybdenum Project, spanning 4,700-hectares located in the Bulkley Porphyry Belt in central British Columbia.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

VANCOUVER, British Columbia, May 19, 2026 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that it has commenced a 32.4 km^(2) induced polarization (“IP”) geophysical survey on its 100% owned Stars Property (“Stars” or the “Property”). Stars is a porphyry copper-molybdenum (“Cu-Mo”) project covering 9,693 hectares (“ha”) in the Stikine region of British Columbia, situated approximately 60 km north of Imperial Metals Corporation’s (“Imperial Metals”) past producing Huckleberry Cu-Mo mine, 50 km north-northeast of Surge Copper Corp’s advanced stage Berg copper project, and 30 km north-northwest of Vizsla Copper Corp’s Poplar copper-gold project. Imperial Metals is exploring Huckleberry and its surrounding claims for additional Cu-Mo resources.

This very large IP survey represents the first time this geophysical technique has been applied across the full extent of the Stars Property, including over the Tana Zone discovery area and its along-strike extensions. Induced polarization is a proven method for detecting sulphide mineralization, the type of copper-bearing material found at Stars, at depth and at distance from known drill holes. By imaging the full 32.4 km² footprint of the magnetic anomaly, the Company aims to determine the true scale of the mineralized system in terms of strike length, width, and depth, and to identify potential new drill targets beyond the current Tana Zone.

Highlights of the Stars Property:

• Road accessible, 9,693 ha property in a top tier exploration and mining district, the Bulkley Porphyry Belt.
• A 230 X 180 metre (“m”) domain (the “Tana Zone”) of chalcopyrite-molybdenite-bornite quartz stockwork that has been intersected from surface to greater than 350 m depth. The zone is open in two directions as well as to depth. Drill Intersection highlights include:
  • 0.466% Cu over 195.07 m* in drill hole DD18SS004 from 23.47 m
  • 0.200% Cu over 396.67 m* in drill hole DD18SS010 from 29.37 m
  • 0.205% Cu over 207.27 m* in drill hole DD18SS015 from 163.98 m
• A highly prospective, approximately 5 X 2.5 kilometre (“km”), annular magnetic anomaly that is interpreted as an altered monzonite intrusion and surrounding hornfels (Figure 1).
• Numerous underexplored soil and induced polarization geophysical targets within the larger magnetic anomaly (Figure 1).

Brian Thurston, President & CEO of Copper Quest, commented: "Copper Quest controls 9,693 ha covering the Stars Property and prospective surrounding area with two complementary exploration upsides being an established zone of higher-grade mineralization that the Company can grow and define, and a much broader under-explored area with high potential for new discovery. This is a very large geophysical program that combined with the historic 9,016 m of drilling will help guide exploration to provide the best information to make new discoveries in this very large anomaly that has a footprint five times that of the Huckleberry Mine. Combined with the contiguous 5,389 ha Stellar Property, Copper Quest has assembled a dominant land position and created a unique opportunity that unlocks a district scale copper porphyry project in the Bulkley Porphyry Belt. Given the global movement towards AI, electrification, environmental concerns, infrastructure development, and the forecasted demand for copper, the combined properties make a very compelling exploration package."

The Stars Property

The 9,693 ha, road-accessible Stars Property is located in central British Columbia, 40 km southwest of Houston. It hosts porphyry copper-molybdenum mineralization associated with a Bulkley Suite monzonite stock. The Bulkley Suite is linked to mineralization at Imperial Metals' past-producing Huckleberry mine, 60 km to the south, and other porphyry deposits in the region. Three drilling campaigns on the Stars Property, totaling 9,016 m, have identified a broad area of anomalous copper, and molybdenum within the monzonite stock. The most important drilling to date is at the Tana Zone (Figure 1), where the contact between the stock and surrounding volcanic rock contains chalcopyrite, molybdenite and bornite bearing quartz stockwork veining. Tana Zone drilling has defined an approximately 230 x 180 m domain with significant copper and molybdenum grades (Table 1).

Table 1: Highlights of Tana Zone Intersections*

https://preview.redd.it/nnnl1q6cmh2h1.png?width=1508&format=png&auto=webp&s=a6be72690b0d5c79f1e7801fea1b4c799463a46f

Outside the Tana Zone, most drilling on the property encountered altered and anomalous mineralized monzonite within an approximately 1.8 x 1.0 km area marked by a broad magnetic low (Fig. 1). While there is potential for an undiscovered porphyry deposit within the monzonite intrusion, Copper Quest's future exploration will concentrate on specific IP targets along the contact zones. Several historical drill holes are believed to have approached this contact, with assays at their bottoms showing increased copper and molybdenite values (Table 2). Their drill logs also indicate an increase in quartz-chalcopyrite-molybdenite ± bornite veins with pink K-feldspar altered selvages, similar to those found in the Tana Zone.

Table 2: Drill intersections indicating grassroots exploration opportunities*

https://preview.redd.it/faphvlzemh2h1.png?width=1508&format=png&auto=webp&s=15560d57ccc5a82dd2e928170ed68412c308e34f

* True width of historical drill intersections referenced in this press release are unknown. Historical drill data in this release is derived from previous exploration activities conducted by other parties. While this data may provide insights into the mineralization potential on the property, it should not be relied upon as conclusive evidence of mineral potential or project viability.

https://preview.redd.it/0myp8mpjmh2h1.png?width=1144&format=png&auto=webp&s=b54f95c60d90a63f5fbf3c87ee57f0b8da265e42

Map of Exploration Targets on the Stars Property. Datum NAD83 UTM Zone 9. Historical drilling and exploration vectors on total-magnetic-intensity geophysical map

Figure 1: Map of Exploration Targets on the Stars Property. Datum NAD83 UTM Zone 9. Historical drilling and exploration vectors on total-magnetic-intensity geophysical map.

Qualified Person

Brian Thurston, P.Geo., the Company’s President, CEO and a qualified person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information in this news release.

About Copper

Copper is an essential industrial metal at the heart of the global energy transition and modern infrastructure. It plays a critical role in electrification, renewable energy systems, electric vehicles, data centers, and smart technologies. With global demand rising and new supply challenged by declining grades, complex permitting, and underinvestment, the copper market faces persistent deficits and growing geopolitical scrutiny. Recent U.S. policy announcements, including import tariffs and initiatives to secure domestic and allied supply chains, underscore copper’s strategic importance and the need for resilient, localized resource exploration, development, production and processing capacity.

About Copper Quest Exploration Inc.

The Company's land holdings comprise 8 projects that span over 46,000 hectares in great mining jurisdictions of Canada and the USA. Copper Quest is committed to building shareholder value through acquisitions, discovery-driven exploration, and responsible development of its North American portfolio of assets. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”. For more information on Copper Quest, please visit the Company’s website at www.copper.quest.

Copper Quest has a 100% interest in the past-producing Alpine Gold Mine located approximately 20 kilometers northeast of the City of Nelson British Columbia, spanning 4,611.49 hectares with a 2018 National Instrument 43-101 Standards of Disclosure for Mineral Projects historical inferred resource of 268,000 tonnes, estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au, that represents an inferred resource of 142,000 oz of gold* (*McCuaig & Giroux, March 6, 2018, NI43-101 Technical Report for the Alpine Property, BC, Canada. Further drilling is necessary by the Company to upgrade/verify the estimate. The QP has not done sufficient work to make the resource current and the Company is not treating the estimate as current.). Apart from the Alpine Mine itself the property hosts 4 other less explored significant vein systems including the past-producing King Solomon vein workings, the Black Prince and the Cold Blow veins system, and the Gold Crown vein system. *The Company has not yet completed sufficient work to verify the 2018 historic inferred resource results.

Copper Quest has a 100% interest in the road accessible Stars Porphyry Copper-Molybdenum Property, spanning 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt with Tana Zone discovery drill intersection highlights of 0.466% Cu over 195.07m in drill hole DD18SS004 from 23.47m, 0.200% Cu over 396.67m in drill hole DD18SS010 from 29.37m, and 0.205% Cu over 207.27m in drill hole DD18SS015 from 163.98m. This highly prospective, approximately 5X2.5-kilometer annular magnetic anomaly is interpreted to represent an altered monzonite intrusion and surrounding hornfels.

Copper Quest has a 100% interest in the road accessible Kitimat Copper-Gold Property, spanning 2,954 hectares within the Skeena Mining Division of northwestern British Columbia located northwest of the deep-water port community of Kitimat, British Columbia. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines. Exploration on the Kitimat property dates to the late 1960s, with the most significant historical work conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone, and drill intersection highlights of 0.54% Cu and 1.03 g/t Au over 117.07 m in Hole J-7 from 1.52 m, 0.55% Cu and 1.00 g/t Au over 103.65m in Hole J-1 from 9.15 m, 0.45% Cu and 0.80 g/t Au over 107.01m in Hole J-2 from 6.10 m, and 0.33% Cu and 0.41 g/t Au over 112.20m in Hole J-8 from 11.89 m.

Copper Quest has a 100% interest in the past-producing, road accessible Auxer Gold Mine, spanning 1,087 hectares located in Bonner County, Idaho, USA. This orogenic gold opportunity is positioned along one of the region’s most significant structural corridors located within the prolific Hope Fault system. Historical exploration has demonstrated exceptional gold grades, with the 1936 Platts report documenting up to 21.0 g/t Au in surface samples and underground workings showing consistent mineralization over 4.3-meter widths averaging 9.42 g/t Au at an 18-meter depth.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, USA, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the road accessible Stellar Property, spanning 5,389-hectares in British Columbia’s Bulkley Porphyry Belt contiguous to the Stars Property.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern British Columbia spanning over 20,658 hectares with 10 priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest has an earn-in option of up to 80% and joint-venture agreement on the road accessible Rip Porphyry Copper-Molybdenum Project, spanning 4,700-hectares located in the Bulkley Porphyry Belt in central British Columbia.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Cybersecurity basket: PANW, CRWD, FTNT, ZS, and SWISF offer five different levels of cyber exposure, from mega-cap platforms to a micro-cap secure-communications play.
• Sector catalyst: worldwide information-security spending is projected around US$200B–US$240B in 2026, while AI, cloud, ransomware, and data-sovereignty risks keep cyber budgets elevated.
• Micro-cap angle: Sekur Private Data (OTCQB: SWISF) trades around US$0.043, with market cap near US$10M–US$11M, giving it higher risk but more torque if adoption improves.

Cybersecurity remains one of the strongest long-term technology themes in the market. Companies are moving more workloads to the cloud, employees are spread across more devices and locations, AI is making attacks more sophisticated, and governments are treating digital infrastructure as a national-security priority.

For investors, the cyber trade is not just about buying the biggest names. The better question is: which companies are growing revenue, expanding recurring contracts, defending margins, and still have room for valuation upside? That is why this basket combines four scaled cybersecurity leaders with one speculative micro-cap, Sekur Private Data (SWISF), focused on secure communications and privacy tools.

Market Catalyst: Cybersecurity Is Becoming Core Infrastructure

Cybersecurity is no longer just an IT expense. Industry estimates point to worldwide information-security spending of roughly US$200B–US$240B in 2026, while AI-driven attacks, ransomware, identity theft, cloud vulnerabilities, and nation-state threats keep security budgets high even when other software categories slow down.

The investment setup is clear: cyber companies with strong recurring revenue, high gross margins, sticky customers, and platform expansion can keep compounding. The risk is valuation. Many large-cap cyber names already trade at premium multiples, which means investors need to watch revenue growth, billings, ARR, free cash flow, and guidance closely.

1. Palo Alto Networks: The Platform Leader

Palo Alto Networks (NASDAQ: PANW) remains one of the largest and most important cybersecurity companies in the public market. Recent market data showed PANW trading around US$193 per share, with a market cap near US$137B.

The company’s latest fiscal Q2 2026 results showed US$2.6B in revenue, up 15% year over year. More importantly for investors, Next-Generation Security ARR grew 33% to US$6.3B, and remaining performance obligations reached US$16.0B, up 23%. Management also guided for fiscal 2026 revenue of US$11.28B–US$11.31B, up 22%–23%, with adjusted free cash flow margin around 37%.

The upside case is platform consolidation. Large companies want fewer vendors and broader security coverage, which favors PANW. The risk is that at a large-cap valuation, the stock needs continued execution to keep moving higher.

https://preview.redd.it/tad9v5t4kh2h1.png?width=1568&format=png&auto=webp&s=c3a50a01ad96e92ed9469cf48a502df2904e5722

2. CrowdStrike: Endpoint Security and AI Threat Detection

CrowdStrike (NASDAQ: CRWD) is one of the best-known names in endpoint security and cloud-native cyber protection. Recent market data showed CRWD trading around US$497 per share, with a market cap near US$125B.

CrowdStrike’s fiscal Q1 2026 results showed US$1.10B in revenue, up 20% year over year. Subscription revenue was US$1.05B, also up 20%, while ending ARR reached US$4.44B, up 22%. The company also generated US$384M in operating cash flow and US$279M in free cash flow during the quarter.

For investors, the key number is ARR. If CrowdStrike can keep expanding beyond endpoint into identity, cloud, SIEM, and AI security, the platform story stays strong. The risk is valuation: CRWD trades like a premium growth company, so any slowdown can hit the multiple quickly.

https://preview.redd.it/4mpoeve6kh2h1.png?width=1568&format=png&auto=webp&s=226782f0b0897efa06cd8db1cc7f6beef0714864

3. Fortinet: Firewalls, SASE, and Profitable Growth

Fortinet (NASDAQ: FTNT) is one of the more established cybersecurity names, with exposure to firewalls, network security, secure access, and SASE. Recent market data showed FTNT trading around US$107, with a market cap near US$81B.

The latest Q1 2026 numbers were strong. Revenue grew 20% year over year to US$1.85B, product revenue jumped 41% to US$645M, and billings rose 31% to US$2.09B. Fortinet also reported 31% GAAP operating margin, 36% non-GAAP operating margin, US$1.08B in operating cash flow, and US$1.01B in free cash flow.

That makes FTNT one of the more profitability-focused names in the basket. The investor case is that Fortinet can benefit as companies modernize network security and secure distributed workforces. The risk is that firewall cycles can be uneven, so investors need to see billings strength continue.

https://preview.redd.it/imuc82y7kh2h1.png?width=1568&format=png&auto=webp&s=95c852d5ba2494347ed031217054b8df8f8f0219

4. Zscaler: Zero Trust and Cloud Security

Zscaler (NASDAQ: ZS) is one of the purest public-market plays on zero trust and cloud-based secure access. Recent market data showed ZS trading around US$149 per share, with a market cap near US$24B.

Zscaler’s fiscal Q2 2026 update raised the company’s full-year outlook. Management guided for fiscal 2026 revenue of US$3.309B–US$3.322B, up about 24%, and ARR of US$3.730B–US$3.745B, also up about 24%. Non-GAAP operating income guidance was lifted to US$742M–US$748M, implying stronger operating leverage alongside growth.

The investor case is zero trust. As companies move away from old network perimeters, Zscaler’s cloud security architecture becomes more relevant. The risk is that ZS still needs to keep balancing growth, profitability, and valuation discipline.

https://preview.redd.it/gzyj3o99kh2h1.png?width=1568&format=png&auto=webp&s=4acdffc9a762b2c8f1a51fe4a9ec3c1653850c6f

5. Sekur Private Data: The Micro-Cap Secure Communications Play

Sekur Private Data (OTCQB: SWISF) is the small-cap outlier in this cyber tech basket. Unlike Palo Alto, CrowdStrike, Fortinet, or Zscaler, Sekur is not trying to dominate enterprise security platforms at scale. Its angle is narrower: Swiss-hosted secure communications, encrypted email, private messaging, VPN services, and privacy-first enterprise tools.

Recent market data showed SWISF around US$0.043, with a market cap near US$10M–US$11M and roughly 253M shares outstanding. That is tiny compared with PANW, CRWD, FTNT, and ZS. It also means Sekur needs far less revenue to potentially change investor perception.

The company has discussed premium products such as Sekur Platinum, reportedly priced around US$7,000 per year per user without phones and US$8,500 per year per user with the SekurPhone Platinum package. In simple terms, 500 premium users at US$7,000/year would equal US$3.5M in annual revenue, while 1,500 users would equal US$10.5M before any consumer or enterprise-plan revenue.

Recent additions, including retired U.S. Army Lt. Gen. Raymond Palumbo and former CIA technology leader John T. Lewis, give SWISF a stronger credibility story as Sekur tries to move deeper into government, defense, and enterprise secure communications. The risk is execution: Sekur still needs paid adoption, revenue growth, and contract traction.

https://preview.redd.it/vga01pe3lh2h1.png?width=1568&format=png&auto=webp&s=34a737ff7b60e078b8ad6c3eb0459b673ad0c302

Stock Snapshot

https://preview.redd.it/6yiq6bl4lh2h1.png?width=1546&format=png&auto=webp&s=ab1df235baae504318916d354093d75945511b31

Bottom Line

Cybersecurity remains one of the strongest long-term technology themes because digital risk keeps rising. AI can make attackers faster, cloud adoption expands the attack surface, and companies cannot afford to underinvest in core security.

For investors, PANW, CRWD, FTNT, ZS, and SWISF each offer a different type of cyber exposure. Palo Alto is the platform consolidator. CrowdStrike is the endpoint and AI security leader. Fortinet is the profitable network-security compounder. Zscaler is the zero-trust cloud security play. Sekur is the speculative secure-communications micro-cap.

The large-cap names already have scale, but they also need to justify premium valuations. SWISF has the opposite setup: far smaller, much riskier, but potentially more sensitive to even modest enterprise or government traction. That makes the basket useful for investors who want both established cybersecurity leaders and one higher-risk watchlist name tied to secure communications.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Cybersecurity basket: PANW, CRWD, FTNT, ZS, and SWISF offer five different levels of cyber exposure, from mega-cap platforms to a micro-cap secure-communications play.
• Sector catalyst: worldwide information-security spending is projected around US$200B–US$240B in 2026, while AI, cloud, ransomware, and data-sovereignty risks keep cyber budgets elevated.
• Micro-cap angle: Sekur Private Data (OTCQB: SWISF) trades around US$0.043, with market cap near US$10M–US$11M, giving it higher risk but more torque if adoption improves.

Cybersecurity remains one of the strongest long-term technology themes in the market. Companies are moving more workloads to the cloud, employees are spread across more devices and locations, AI is making attacks more sophisticated, and governments are treating digital infrastructure as a national-security priority.

For investors, the cyber trade is not just about buying the biggest names. The better question is: which companies are growing revenue, expanding recurring contracts, defending margins, and still have room for valuation upside? That is why this basket combines four scaled cybersecurity leaders with one speculative micro-cap, Sekur Private Data (SWISF), focused on secure communications and privacy tools.

Market Catalyst: Cybersecurity Is Becoming Core Infrastructure

Cybersecurity is no longer just an IT expense. Industry estimates point to worldwide information-security spending of roughly US$200B–US$240B in 2026, while AI-driven attacks, ransomware, identity theft, cloud vulnerabilities, and nation-state threats keep security budgets high even when other software categories slow down.

The investment setup is clear: cyber companies with strong recurring revenue, high gross margins, sticky customers, and platform expansion can keep compounding. The risk is valuation. Many large-cap cyber names already trade at premium multiples, which means investors need to watch revenue growth, billings, ARR, free cash flow, and guidance closely.

1. Palo Alto Networks: The Platform Leader

Palo Alto Networks (NASDAQ: PANW) remains one of the largest and most important cybersecurity companies in the public market. Recent market data showed PANW trading around US$193 per share, with a market cap near US$137B.

The company’s latest fiscal Q2 2026 results showed US$2.6B in revenue, up 15% year over year. More importantly for investors, Next-Generation Security ARR grew 33% to US$6.3B, and remaining performance obligations reached US$16.0B, up 23%. Management also guided for fiscal 2026 revenue of US$11.28B–US$11.31B, up 22%–23%, with adjusted free cash flow margin around 37%.

The upside case is platform consolidation. Large companies want fewer vendors and broader security coverage, which favors PANW. The risk is that at a large-cap valuation, the stock needs continued execution to keep moving higher.

https://preview.redd.it/zm8v44yhjh2h1.png?width=1568&format=png&auto=webp&s=08ad27d31d9a2a24c79885e002e9dc1286c23655

2. CrowdStrike: Endpoint Security and AI Threat Detection

CrowdStrike (NASDAQ: CRWD) is one of the best-known names in endpoint security and cloud-native cyber protection. Recent market data showed CRWD trading around US$497 per share, with a market cap near US$125B.

CrowdStrike’s fiscal Q1 2026 results showed US$1.10B in revenue, up 20% year over year. Subscription revenue was US$1.05B, also up 20%, while ending ARR reached US$4.44B, up 22%. The company also generated US$384M in operating cash flow and US$279M in free cash flow during the quarter.

For investors, the key number is ARR. If CrowdStrike can keep expanding beyond endpoint into identity, cloud, SIEM, and AI security, the platform story stays strong. The risk is valuation: CRWD trades like a premium growth company, so any slowdown can hit the multiple quickly.

https://preview.redd.it/zzh6ec8jjh2h1.png?width=1568&format=png&auto=webp&s=c26990b1e979257b2384b0c9a1489e6d9f641d25

3. Fortinet: Firewalls, SASE, and Profitable Growth

Fortinet (NASDAQ: FTNT) is one of the more established cybersecurity names, with exposure to firewalls, network security, secure access, and SASE. Recent market data showed FTNT trading around US$107, with a market cap near US$81B.

The latest Q1 2026 numbers were strong. Revenue grew 20% year over year to US$1.85B, product revenue jumped 41% to US$645M, and billings rose 31% to US$2.09B. Fortinet also reported 31% GAAP operating margin, 36% non-GAAP operating margin, US$1.08B in operating cash flow, and US$1.01B in free cash flow.

That makes FTNT one of the more profitability-focused names in the basket. The investor case is that Fortinet can benefit as companies modernize network security and secure distributed workforces. The risk is that firewall cycles can be uneven, so investors need to see billings strength continue.

https://preview.redd.it/vo7p4r0ljh2h1.png?width=1568&format=png&auto=webp&s=57800d4fa1341f14a9487537a4a6e9c74b948fee

4. Zscaler: Zero Trust and Cloud Security

Zscaler (NASDAQ: ZS) is one of the purest public-market plays on zero trust and cloud-based secure access. Recent market data showed ZS trading around US$149 per share, with a market cap near US$24B.

Zscaler’s fiscal Q2 2026 update raised the company’s full-year outlook. Management guided for fiscal 2026 revenue of US$3.309B–US$3.322B, up about 24%, and ARR of US$3.730B–US$3.745B, also up about 24%. Non-GAAP operating income guidance was lifted to US$742M–US$748M, implying stronger operating leverage alongside growth.

The investor case is zero trust. As companies move away from old network perimeters, Zscaler’s cloud security architecture becomes more relevant. The risk is that ZS still needs to keep balancing growth, profitability, and valuation discipline.

https://preview.redd.it/6dqli80njh2h1.png?width=1568&format=png&auto=webp&s=64b31e1703761ba3417a48e9132cd244ff514ad1

5. Sekur Private Data: The Micro-Cap Secure Communications Play

Sekur Private Data (OTCQB: SWISF) is the small-cap outlier in this cyber tech basket. Unlike Palo Alto, CrowdStrike, Fortinet, or Zscaler, Sekur is not trying to dominate enterprise security platforms at scale. Its angle is narrower: Swiss-hosted secure communications, encrypted email, private messaging, VPN services, and privacy-first enterprise tools.

Recent market data showed SWISF around US$0.043, with a market cap near US$10M–US$11M and roughly 253M shares outstanding. That is tiny compared with PANW, CRWD, FTNT, and ZS. It also means Sekur needs far less revenue to potentially change investor perception.

The company has discussed premium products such as Sekur Platinum, reportedly priced around US$7,000 per year per user without phones and US$8,500 per year per user with the SekurPhone Platinum package. In simple terms, 500 premium users at US$7,000/year would equal US$3.5M in annual revenue, while 1,500 users would equal US$10.5M before any consumer or enterprise-plan revenue.

Recent additions, including retired U.S. Army Lt. Gen. Raymond Palumbo and former CIA technology leader John T. Lewis, give SWISF a stronger credibility story as Sekur tries to move deeper into government, defense, and enterprise secure communications. The risk is execution: Sekur still needs paid adoption, revenue growth, and contract traction.

https://preview.redd.it/vf66kvvqjh2h1.png?width=1568&format=png&auto=webp&s=4245f7770ce74a716ec21f3d896727d270656925

Stock Snapshot

https://preview.redd.it/bm9z6r7sjh2h1.png?width=1546&format=png&auto=webp&s=69072f5942ba53b74ffe57a663f0a94a75972b64

Bottom Line

Cybersecurity remains one of the strongest long-term technology themes because digital risk keeps rising. AI can make attackers faster, cloud adoption expands the attack surface, and companies cannot afford to underinvest in core security.

For investors, PANW, CRWD, FTNT, ZS, and SWISF each offer a different type of cyber exposure. Palo Alto is the platform consolidator. CrowdStrike is the endpoint and AI security leader. Fortinet is the profitable network-security compounder. Zscaler is the zero-trust cloud security play. Sekur is the speculative secure-communications micro-cap.

The large-cap names already have scale, but they also need to justify premium valuations. SWISF has the opposite setup: far smaller, much riskier, but potentially more sensitive to even modest enterprise or government traction. That makes the basket useful for investors who want both established cybersecurity leaders and one higher-risk watchlist name tied to secure communications.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Cybersecurity basket: PANW, CRWD, FTNT, ZS, and SWISF offer five different levels of cyber exposure, from mega-cap platforms to a micro-cap secure-communications play.
• Sector catalyst: worldwide information-security spending is projected around US$200B–US$240B in 2026, while AI, cloud, ransomware, and data-sovereignty risks keep cyber budgets elevated.
• Micro-cap angle: Sekur Private Data (OTCQB: SWISF) trades around US$0.043, with market cap near US$10M–US$11M, giving it higher risk but more torque if adoption improves.

Cybersecurity remains one of the strongest long-term technology themes in the market. Companies are moving more workloads to the cloud, employees are spread across more devices and locations, AI is making attacks more sophisticated, and governments are treating digital infrastructure as a national-security priority.

For investors, the cyber trade is not just about buying the biggest names. The better question is: which companies are growing revenue, expanding recurring contracts, defending margins, and still have room for valuation upside? That is why this basket combines four scaled cybersecurity leaders with one speculative micro-cap, Sekur Private Data (SWISF), focused on secure communications and privacy tools.

Market Catalyst: Cybersecurity Is Becoming Core Infrastructure

Cybersecurity is no longer just an IT expense. Industry estimates point to worldwide information-security spending of roughly US$200B–US$240B in 2026, while AI-driven attacks, ransomware, identity theft, cloud vulnerabilities, and nation-state threats keep security budgets high even when other software categories slow down.

The investment setup is clear: cyber companies with strong recurring revenue, high gross margins, sticky customers, and platform expansion can keep compounding. The risk is valuation. Many large-cap cyber names already trade at premium multiples, which means investors need to watch revenue growth, billings, ARR, free cash flow, and guidance closely.

1. Palo Alto Networks: The Platform Leader

Palo Alto Networks (NASDAQ: PANW) remains one of the largest and most important cybersecurity companies in the public market. Recent market data showed PANW trading around US$193 per share, with a market cap near US$137B.

The company’s latest fiscal Q2 2026 results showed US$2.6B in revenue, up 15% year over year. More importantly for investors, Next-Generation Security ARR grew 33% to US$6.3B, and remaining performance obligations reached US$16.0B, up 23%. Management also guided for fiscal 2026 revenue of US$11.28B–US$11.31B, up 22%–23%, with adjusted free cash flow margin around 37%.

The upside case is platform consolidation. Large companies want fewer vendors and broader security coverage, which favors PANW. The risk is that at a large-cap valuation, the stock needs continued execution to keep moving higher.

https://preview.redd.it/ct4cuo01jh2h1.png?width=1568&format=png&auto=webp&s=1edf315eb1d595a5392e638ded5e5b98aaf9a790

2. CrowdStrike: Endpoint Security and AI Threat Detection

CrowdStrike (NASDAQ: CRWD) is one of the best-known names in endpoint security and cloud-native cyber protection. Recent market data showed CRWD trading around US$497 per share, with a market cap near US$125B.

CrowdStrike’s fiscal Q1 2026 results showed US$1.10B in revenue, up 20% year over year. Subscription revenue was US$1.05B, also up 20%, while ending ARR reached US$4.44B, up 22%. The company also generated US$384M in operating cash flow and US$279M in free cash flow during the quarter.

For investors, the key number is ARR. If CrowdStrike can keep expanding beyond endpoint into identity, cloud, SIEM, and AI security, the platform story stays strong. The risk is valuation: CRWD trades like a premium growth company, so any slowdown can hit the multiple quickly.

https://preview.redd.it/zq8anqc3jh2h1.png?width=1568&format=png&auto=webp&s=a302ba0a6ab557ce4f70a72e7cea0ab90971e64c

3. Fortinet: Firewalls, SASE, and Profitable Growth

Fortinet (NASDAQ: FTNT) is one of the more established cybersecurity names, with exposure to firewalls, network security, secure access, and SASE. Recent market data showed FTNT trading around US$107, with a market cap near US$81B.

The latest Q1 2026 numbers were strong. Revenue grew 20% year over year to US$1.85B, product revenue jumped 41% to US$645M, and billings rose 31% to US$2.09B. Fortinet also reported 31% GAAP operating margin, 36% non-GAAP operating margin, US$1.08B in operating cash flow, and US$1.01B in free cash flow.

That makes FTNT one of the more profitability-focused names in the basket. The investor case is that Fortinet can benefit as companies modernize network security and secure distributed workforces. The risk is that firewall cycles can be uneven, so investors need to see billings strength continue.

https://preview.redd.it/n2ju4625jh2h1.png?width=1568&format=png&auto=webp&s=0476a5f7a91ecea5b92e030ffcfa6d19de84e1c3

4. Zscaler: Zero Trust and Cloud Security

Zscaler (NASDAQ: ZS) is one of the purest public-market plays on zero trust and cloud-based secure access. Recent market data showed ZS trading around US$149 per share, with a market cap near US$24B.

Zscaler’s fiscal Q2 2026 update raised the company’s full-year outlook. Management guided for fiscal 2026 revenue of US$3.309B–US$3.322B, up about 24%, and ARR of US$3.730B–US$3.745B, also up about 24%. Non-GAAP operating income guidance was lifted to US$742M–US$748M, implying stronger operating leverage alongside growth.

The investor case is zero trust. As companies move away from old network perimeters, Zscaler’s cloud security architecture becomes more relevant. The risk is that ZS still needs to keep balancing growth, profitability, and valuation discipline.

https://preview.redd.it/d8s6udi6jh2h1.png?width=1568&format=png&auto=webp&s=624e57687ca8d9ca2cea8ded1ecd33a8871a518c

5. Sekur Private Data: The Micro-Cap Secure Communications Play

Sekur Private Data (OTCQB: SWISF) is the small-cap outlier in this cyber tech basket. Unlike Palo Alto, CrowdStrike, Fortinet, or Zscaler, Sekur is not trying to dominate enterprise security platforms at scale. Its angle is narrower: Swiss-hosted secure communications, encrypted email, private messaging, VPN services, and privacy-first enterprise tools.

Recent market data showed SWISF around US$0.043, with a market cap near US$10M–US$11M and roughly 253M shares outstanding. That is tiny compared with PANW, CRWD, FTNT, and ZS. It also means Sekur needs far less revenue to potentially change investor perception.

The company has discussed premium products such as Sekur Platinum, reportedly priced around US$7,000 per year per user without phones and US$8,500 per year per user with the SekurPhone Platinum package. In simple terms, 500 premium users at US$7,000/year would equal US$3.5M in annual revenue, while 1,500 users would equal US$10.5M before any consumer or enterprise-plan revenue.

Recent additions, including retired U.S. Army Lt. Gen. Raymond Palumbo and former CIA technology leader John T. Lewis, give SWISF a stronger credibility story as Sekur tries to move deeper into government, defense, and enterprise secure communications. The risk is execution: Sekur still needs paid adoption, revenue growth, and contract traction.

https://preview.redd.it/dh1bjs78jh2h1.png?width=1568&format=png&auto=webp&s=eb8616dd603c8050cad73233f177719e5a37c750

Stock Snapshot

https://preview.redd.it/oe00mfh9jh2h1.png?width=1546&format=png&auto=webp&s=1205d716f43db7910576993d9193269c7301292e

Bottom Line

Cybersecurity remains one of the strongest long-term technology themes because digital risk keeps rising. AI can make attackers faster, cloud adoption expands the attack surface, and companies cannot afford to underinvest in core security.

For investors, PANW, CRWD, FTNT, ZS, and SWISF each offer a different type of cyber exposure. Palo Alto is the platform consolidator. CrowdStrike is the endpoint and AI security leader. Fortinet is the profitable network-security compounder. Zscaler is the zero-trust cloud security play. Sekur is the speculative secure-communications micro-cap.

The large-cap names already have scale, but they also need to justify premium valuations. SWISF has the opposite setup: far smaller, much riskier, but potentially more sensitive to even modest enterprise or government traction. That makes the basket useful for investors who want both established cybersecurity leaders and one higher-risk watchlist name tied to secure communications.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

• Cybersecurity basket: PANW, CRWD, FTNT, ZS, and SWISF offer five different levels of cyber exposure, from mega-cap platforms to a micro-cap secure-communications play.
• Sector catalyst: worldwide information-security spending is projected around US$200B–US$240B in 2026, while AI, cloud, ransomware, and data-sovereignty risks keep cyber budgets elevated.
• Micro-cap angle: Sekur Private Data (OTCQB: SWISF) trades around US$0.043, with market cap near US$10M–US$11M, giving it higher risk but more torque if adoption improves.

Cybersecurity remains one of the strongest long-term technology themes in the market. Companies are moving more workloads to the cloud, employees are spread across more devices and locations, AI is making attacks more sophisticated, and governments are treating digital infrastructure as a national-security priority.

For investors, the cyber trade is not just about buying the biggest names. The better question is: which companies are growing revenue, expanding recurring contracts, defending margins, and still have room for valuation upside? That is why this basket combines four scaled cybersecurity leaders with one speculative micro-cap, Sekur Private Data (SWISF), focused on secure communications and privacy tools.

Market Catalyst: Cybersecurity Is Becoming Core Infrastructure

Cybersecurity is no longer just an IT expense. Industry estimates point to worldwide information-security spending of roughly US$200B–US$240B in 2026, while AI-driven attacks, ransomware, identity theft, cloud vulnerabilities, and nation-state threats keep security budgets high even when other software categories slow down.

The investment setup is clear: cyber companies with strong recurring revenue, high gross margins, sticky customers, and platform expansion can keep compounding. The risk is valuation. Many large-cap cyber names already trade at premium multiples, which means investors need to watch revenue growth, billings, ARR, free cash flow, and guidance closely.

1. Palo Alto Networks: The Platform Leader

Palo Alto Networks (NASDAQ: PANW) remains one of the largest and most important cybersecurity companies in the public market. Recent market data showed PANW trading around US$193 per share, with a market cap near US$137B.

The company’s latest fiscal Q2 2026 results showed US$2.6B in revenue, up 15% year over year. More importantly for investors, Next-Generation Security ARR grew 33% to US$6.3B, and remaining performance obligations reached US$16.0B, up 23%. Management also guided for fiscal 2026 revenue of US$11.28B–US$11.31B, up 22%–23%, with adjusted free cash flow margin around 37%.

The upside case is platform consolidation. Large companies want fewer vendors and broader security coverage, which favors PANW. The risk is that at a large-cap valuation, the stock needs continued execution to keep moving higher.

https://preview.redd.it/cktrjf58hh2h1.png?width=1568&format=png&auto=webp&s=3b663021c04a55b957821de6f707e4f9520a068e

2. CrowdStrike: Endpoint Security and AI Threat Detection

CrowdStrike (NASDAQ: CRWD) is one of the best-known names in endpoint security and cloud-native cyber protection. Recent market data showed CRWD trading around US$497 per share, with a market cap near US$125B.

CrowdStrike’s fiscal Q1 2026 results showed US$1.10B in revenue, up 20% year over year. Subscription revenue was US$1.05B, also up 20%, while ending ARR reached US$4.44B, up 22%. The company also generated US$384M in operating cash flow and US$279M in free cash flow during the quarter.

For investors, the key number is ARR. If CrowdStrike can keep expanding beyond endpoint into identity, cloud, SIEM, and AI security, the platform story stays strong. The risk is valuation: CRWD trades like a premium growth company, so any slowdown can hit the multiple quickly.

https://preview.redd.it/n4tof76ahh2h1.png?width=1568&format=png&auto=webp&s=8f2e32b4c6629a4eb3b6cf1aa2f4184029d00740

3. Fortinet: Firewalls, SASE, and Profitable Growth

Fortinet (NASDAQ: FTNT) is one of the more established cybersecurity names, with exposure to firewalls, network security, secure access, and SASE. Recent market data showed FTNT trading around US$107, with a market cap near US$81B.

The latest Q1 2026 numbers were strong. Revenue grew 20% year over year to US$1.85B, product revenue jumped 41% to US$645M, and billings rose 31% to US$2.09B. Fortinet also reported 31% GAAP operating margin, 36% non-GAAP operating margin, US$1.08B in operating cash flow, and US$1.01B in free cash flow.

That makes FTNT one of the more profitability-focused names in the basket. The investor case is that Fortinet can benefit as companies modernize network security and secure distributed workforces. The risk is that firewall cycles can be uneven, so investors need to see billings strength continue.

https://preview.redd.it/n1lye4hchh2h1.png?width=1568&format=png&auto=webp&s=fb898f28708c9a72d83487e39c580bdb2f888924

4. Zscaler: Zero Trust and Cloud Security

Zscaler (NASDAQ: ZS) is one of the purest public-market plays on zero trust and cloud-based secure access. Recent market data showed ZS trading around US$149 per share, with a market cap near US$24B.

Zscaler’s fiscal Q2 2026 update raised the company’s full-year outlook. Management guided for fiscal 2026 revenue of US$3.309B–US$3.322B, up about 24%, and ARR of US$3.730B–US$3.745B, also up about 24%. Non-GAAP operating income guidance was lifted to US$742M–US$748M, implying stronger operating leverage alongside growth.

The investor case is zero trust. As companies move away from old network perimeters, Zscaler’s cloud security architecture becomes more relevant. The risk is that ZS still needs to keep balancing growth, profitability, and valuation discipline.

https://preview.redd.it/9be2g5sehh2h1.png?width=1568&format=png&auto=webp&s=aef3cbbb400b0704903fc05d42b80b2892d20eab

5. Sekur Private Data: The Micro-Cap Secure Communications Play

Sekur Private Data (OTCQB: SWISF) is the small-cap outlier in this cyber tech basket. Unlike Palo Alto, CrowdStrike, Fortinet, or Zscaler, Sekur is not trying to dominate enterprise security platforms at scale. Its angle is narrower: Swiss-hosted secure communications, encrypted email, private messaging, VPN services, and privacy-first enterprise tools.

Recent market data showed SWISF around US$0.043, with a market cap near US$10M–US$11M and roughly 253M shares outstanding. That is tiny compared with PANW, CRWD, FTNT, and ZS. It also means Sekur needs far less revenue to potentially change investor perception.

The company has discussed premium products such as Sekur Platinum, reportedly priced around US$7,000 per year per user without phones and US$8,500 per year per user with the SekurPhone Platinum package. In simple terms, 500 premium users at US$7,000/year would equal US$3.5M in annual revenue, while 1,500 users would equal US$10.5M before any consumer or enterprise-plan revenue.

Recent additions, including retired U.S. Army Lt. Gen. Raymond Palumbo and former CIA technology leader John T. Lewis, give SWISF a stronger credibility story as Sekur tries to move deeper into government, defense, and enterprise secure communications. The risk is execution: Sekur still needs paid adoption, revenue growth, and contract traction.

https://preview.redd.it/eo2ew75ihh2h1.png?width=1568&format=png&auto=webp&s=ade0ea0d38f14aec8842c8ea99e701e60e667813

Stock Snapshot

https://preview.redd.it/uj78461mhh2h1.png?width=1546&format=png&auto=webp&s=d35d79b2d1f62503221cbec36908f8cd3507294b

Bottom Line

Cybersecurity remains one of the strongest long-term technology themes because digital risk keeps rising. AI can make attackers faster, cloud adoption expands the attack surface, and companies cannot afford to underinvest in core security.

For investors, PANW, CRWD, FTNT, ZS, and SWISF each offer a different type of cyber exposure. Palo Alto is the platform consolidator. CrowdStrike is the endpoint and AI security leader. Fortinet is the profitable network-security compounder. Zscaler is the zero-trust cloud security play. Sekur is the speculative secure-communications micro-cap.

The large-cap names already have scale, but they also need to justify premium valuations. SWISF has the opposite setup: far smaller, much riskier, but potentially more sensitive to even modest enterprise or government traction. That makes the basket useful for investors who want both established cybersecurity leaders and one higher-risk watchlist name tied to secure communications.

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.